Category: ACN Newswire

Vancouver, BC, Oct 13, 2026 - (ACN Newswire via SeaPRwire.com) - Doubleview Gold Corp. (TSXV: DBG) (OTCQX: DBLVF) (FSE: 1D4) ("Doubleview" or the "Company") is pleased to announce the appointment of George B. Darling, P.Eng., as Advisor to the Board of Directors. Mr. Darling brings more than 25 years of mine engineering, project management, mine operations, due diligence and EPCM management experience, with particular depth in feasibility studies, mine planning, financial evaluations, project execution and mine development.Mr. Darling's appointment is intended to strengthen Doubleview's senior technical and project-development capacity as the Company continues to advance its 100%-owned Hat Polymetallic Project in northwestern British Columbia. The Hat Project hosts a copper-gold-cobalt-silver-scandium porphyry system and has moved through important technical milestones, including mineral resource and preliminary economic assessment work. The Company expects Mr. Darling's experience to support Board-level review of mine engineering strategy, study planning, project risk, development options and the transition toward more advanced engineering studies.Appointment HighlightsOver 25 years of experience in mine engineering, mine operations, project management, due diligence, EPCM management and mine organizational structures.Experience includes NI 43-101 technical reports, mine feasibility studies, life-of-mine planning, financial evaluations, trade-off studies, mine construction management and development strategies.Held senior mining and engineering roles with Sandstorm, Hatch, SNC-Lavalin, Stantec, SRK Consulting, Inco Ltd. and Inco Gold.Extensive background in feasibility, planning, construction, commissioning and operations phases for new and existing mining operations.Professional Engineer registered in Ontario and Quebec, with additional board, industry and technical advisory experience.George B. Darling, P.Eng.Mr. Darling has held senior technical and leadership roles across the mining industry, including Senior Vice President Engineering at Sandstorm, where his responsibilities included worldwide mining projects and due diligence property evaluations; Director Mining at Hatch, where he was responsible for international mining projects; and Director Mining at SNC-Lavalin, where he managed mining work worldwide for SNC M&M, including feasibility studies and EPCM mandates.Earlier in his career, Mr. Darling served as Managing Principal, Mining at Stantec and Principal Mining Engineer at SRK Consulting, where his work included feasibility and pre-feasibility studies. His operating background includes senior engineering, project management, mine superintendent, site/mine management and supervisory roles with Inco-related operations in Ontario, Quebec and New Caledonia.Mr. Darling holds a B.Sc. in Mining from Queen's University and a B.Sc. in Geology and Geophysics from the University of Sydney. He is a Professional Engineer in Ontario and Quebec. His governance and industry background includes the ICD Board Management course, service on technical and educational boards, and national leadership within the CIM Underground Mining Society.Role with DoubleviewAs Advisor to the Board, Mr. Darling will provide independent strategic and technical guidance to Doubleview's Board and management team on mining, engineering and development matters related to the Hat Project and other opportunities that may be reviewed by the Company. His role is advisory and does not constitute appointment as a director or officer of the Company.The Company believes Mr. Darling's practical mine development and study-execution background is particularly relevant as Doubleview continues to evaluate the scale, development options and next-stage technical work for the Hat Project.CEO CommentFarshad Shirvani, President and CEO of Doubleview Gold Corp., commented:"We are very pleased to welcome George Darling as Advisor to the Board. George brings the kind of senior mine engineering, feasibility-study, project execution and operational experience that becomes increasingly important as the Hat Project advances. His background with major engineering groups, mine operators and technical studies will provide valuable guidance as we continue to build on the technical foundation established at Hat and move the project through its next stages. We believe his experience will help the Board and management assess the Project with discipline, practicality and a clear understanding of what is required to move a large mineral project forward."About the Hat Polymetallic ProjectThe Hat Project is Doubleview's 100%-owned polymetallic porphyry project located in northwestern British Columbia. The Project is being advanced as a copper-gold-cobalt-silver-scandium system, with continuing work focused on resource definition, metallurgy, engineering, environmental studies and development planning. The Company's recent technical work has supported the interpretation of Hat as a large, multi-metal porphyry system with strategic critical-minerals potential.Mineral resources that are not mineral reserves do not have demonstrated economic viability. Any references to the Hat Project's future development, study advancement, engineering work, metallurgical optimization, permitting, or potential economic outcomes are forward-looking in nature and remain subject to technical, environmental, regulatory, financing and market risks, as described under "Forward-Looking Statements" below.Qualified PersonErik Ostensoe, P.Geo., a consulting geologist and Doubleview's Qualified Person with respect to the Hat Project as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects, has reviewed and approved the technical contents of this news release. He is not independent of Doubleview as he is a shareholder of the Company.About Doubleview Gold Corp.Doubleview Gold Corp. is a mineral resource exploration and development company headquartered in Vancouver, British Columbia, Canada. It is publicly traded on the TSX Venture Exchange (TSXV: DBG), OTCQX (DBLVF), and Frankfurt Stock Exchange (FSE: 1D4). Doubleview focuses on identifying, acquiring, exploring and advancing precious, base and critical metals projects, with a strong emphasis on British Columbia.Doubleview's principal asset is the Hat Polymetallic Project in northwestern British Columbia, a copper-gold-cobalt-silver-scandium porphyry project that the Company continues to advance through technical studies and exploration.On behalf of the Board of Directors,Farshad ShirvaniPresident & Chief Executive OfficerFor further information please contact:Doubleview Gold Corp.Farshad Shirvani, President & CEOT: (604) 678-9587E: corporate@doubleview.caW: www.doubleview.caNEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.Forward-Looking StatementsCertain statements contained in this news release may constitute "forward-looking information" within the meaning of applicable Canadian securities laws. Forward-looking information includes, but is not limited to, statements regarding the Company's plans for the Hat Project, future technical studies, engineering work, metallurgical work, exploration, project advancement, development planning, permitting, financing, potential outcomes of advisory work and the expected benefits of Mr. Darling's appointment. Forward-looking information is based on assumptions that management believes to be reasonable at the time such statements are made, including assumptions regarding the availability of financing, technical personnel, contractors, regulatory approvals, equipment, market conditions and exploration or study results.Forward-looking information is subject to risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied, including risks related to mineral exploration and development, changes in commodity prices, metallurgical and engineering results, environmental and permitting matters, First Nations and community engagement, financing availability, regulatory requirements, market conditions and other risks described in the Company's public disclosure. Readers should not place undue reliance on forward-looking information. Except as required by applicable securities laws, the Company undertakes no obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/318684 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

BEIJING, Oct 13, 2026 - (ACN Newswire via SeaPRwire.com) - On September 14, Gartner released its Magic Quadrant™ for Server Virtualization Platforms. H3C CAS is positioned as a Visionary in the 2026 Gartner® Magic Quadrant™ for Server Virtualization Platforms, making H3C one of the few Chinese vendors included in the report. This recognition reflects H3C CAS's continued innovation and capabilities in server virtualization.Beyond Virtualization: A Stable Foundation for Mission-Critical WorkloadsAs cloud computing continues to evolve, server virtualization remains a key foundation for enterprise IT infrastructure. At the same time, the growth of AI, diverse computing architectures, and the coexistence of virtual machines and containers are creating new requirements for virtualization platforms.H3C CAS has evolved from a compute virtualization platform into an enterprise virtualization and cloud management platform covering compute, storage, networking, security, and unified management. It supports x86, ARM, and a broad range of operating systems and hardware.Key capabilities include:1. Improved resource utilization with NVMe SSD-based intelligent memory overcommitment.2. Optimized VM scheduling with automatic VM NUMA binding.3. Support for AI workloads with capabilities such as vGPU live migration.From Virtual Machines to Containers: One Platform for Application ModernizationAs virtual machines and containers increasingly coexist in enterprise data centers, organizations need a unified infrastructure platform to support both traditional and cloud-native applications.H3C CAS integrates virtualization and cloud-native technologies through native Kubernetes integration and container cluster services, enabling unified management of VM and container resources.CAS also provides virtual networking and network services, including Open vSwitch, bandwidth management, traffic prioritization, firewalls, load balancing, and micro-segmentation. Support for RoCE v2 and SR-IOV further enables high-performance and AI workloads.Evolving Virtualization for the AI EraAs IT infrastructure evolves from server virtualization to cloud and AI infrastructure, enterprises continue to require stable, secure, efficient, and future-ready platforms.The Visionary positioning in the Gartner Magic Quadrant reflects the global competitiveness of H3C CAS in server virtualization. Today, CAS serves more than 15,000 customers, with 500,000+ CPUs running online, across industries including government, finance, education, and broadcasting and television.Looking ahead, H3C will continue to integrate server virtualization with AI computing, GPU resource management, and cloud-native technologies, helping customers build more efficient and intelligent infrastructure for next-generation data centers.Disclaimer:Source:Gartner, Magic Quadrant for Server Virtualization Platforms, 14 September 2026GARTNER and Magic Quadrant are registered trademarks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.H3C Jingwen Zeng zeng.jingwen@h3c.com https://www.h3c.com/en/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Hong Kong, Oct 13, 2026 - (ACN Newswire via SeaPRwire.com) - The Hong Kong Electronics Fair (Autumn Edition), organised by the Hong Kong Trade Development Council (HKTDC), and electronicAsia, jointly organised by the HKTDC and MMI Asia Pte Ltd, opened today at the Hong Kong Convention and Exhibition Centre. Running for four consecutive days, the twin fairs showcase a broad spectrum of innovations spanning consumer electronics, artificial intelligence (AI), robotics technologies, smart living, immersive entertainment, electronic components and advanced manufacturing technologies, providing global buyers with a one-stop sourcing and networking platform. Making its debut this year, the Future Industries Zone spotlights five frontier sectors and showcases emerging trends shaping the industries of tomorrow.The Autumn Electronics Fair and eAsia opened today at the Hong Kong Convention and Exhibition Centre, where the fairs will run for four consecutive daysSpeaking at the opening ceremony for the Future Industries Zone this morning, Sophia Chong, HKTDC Executive Director, said: "The Future Industries Zone reflects our commitment to evolve our fairs alongside the industry, while supporting the strategic direction set out in the Policy Address and the First Five-Year Plan to develop Hong Kong into an international innovation and technology centre. This year's Hong Kong Electronics Fair (Autumn Edition) and electronicAsia are bringing together over 3,200 exhibitors from 15 countries and regions. Another key highlight is the expanded RoboPark that showcases not only the latest robotics technologies, but also their growing applications in everyday life and across industries. The HKTDC is one of the core members of the government-led GoGlobal Task Force and we will make good use of one of the world's leading marketplaces to feature the GoGlobal Connect Zone, which offers advisory services and practical support to help enterprises - particularly those from the Chinese Mainland - expand internationally through Hong Kong. The zone reflects the HKTDC's commitment to reinforcing Hong Kong's role as a platform for global expansion, capitalising on its strengths as a superconnector and super value-adder."Sophia Chong, Executive Director of the Hong Kong Trade Development Council, delivers remarks at the opening ceremony for the Future Industries ZoneThe Autumn Electronics Fair has introduced the new Future Industries Zone this year, with an opening ceremony held this morning. Kevin Choi, Permanent Secretary for Innovation, Technology and Industry of HKSARG (front row, fourth from left); Sophia Chong, Executive Director of the Hong Kong Trade Development Council (front row, fourth from right); and Paul So, Chairman of the Hong Kong Electronic Industries Association (front row, third from left), joined the event with other distinguished guestsIn addition to Hong Kong exhibitors, the fairs feature exhibitors from the Chinese Mainland, Macao and Taiwan, as well as countries across the Asia-Pacific region including Korea and Singapore. Exhibitors from Europe and other overseas markets, including Denmark, the United Kingdom, Germany, Switzerland, Spain and Cyprus, are also participating, showcasing a wide range of the latest electronics products and advanced technologies. On the opening day of the fairs, buyers from around the world gathered to explore sourcing opportunities. The HKTDC has organised 130 buying missions comprising buyers from 65 countries and regions to visit and source at the fairs, further reinforcing Hong Kong's role as a platform connecting international markets with innovative supply chains.Future Industries Zone debuts, showcasing synergies across five key themesIn support of the Government's drive to develop Hong Kong into an international innovation and technology centre and deepen AI development and adoption in the city, this year's Autumn Electronics Fair has launched the new Future Industries Zone, jointly organised by the HKTDC and the Hong Kong Electronic Industries Association (HKEIA) and supported by the Innovation, Technology and Industry Bureau of the Hong Kong SAR Government. Led by major innovation and technology institutions, including Cyberport, the Hong Kong Science and Technology Parks Corporation and the Hong Kong Productivity Council, the zone focuses on five key themes: Future Computing, Future Manufacturing, Future Marine & Quantum Technologies, Future Microelectronics and Future Wellness.The newly launched Future Industries Zone at the Autumn Electronics Fair focuses on five key themes: Future Computing, Future Manufacturing, Future Marine & Quantum Technologies, Future Microelectronics and Future WellnessBringing together more than 100 exhibitors, the Future Industries Zone showcases cutting-edge technologies and innovative application solutions. The zone also features a series of thematic forums and networking events, welcoming representatives from government, industry, academia, research and investment sectors to explore opportunities in future industry development. A distinguished lineup of speakers has been invited to share insights on emerging technologies and industry trends. At a thematic forum to be held tomorrow (14 October), experts and representatives from leading global companies and organisations, including AWS, IBM, Lenovo and HPE, will share insights into global trends in cross-industry business transformation and innovation-driven technology development. Other activities also feature a distinguished lineup of speakers, including Prof Wang Yang, Vice-President of The University of Hong Kong; Dr Wang Jun, Deputy Executive President of the Bank of China Group Investment Limited; and He Jun, Vice-President of TCL Industries Holdings Co., Ltd. They will share their professional insights on technology innovation, industrial development and emerging opportunities.GoGlobal Connect Zone offers professional service matching for enterprisesAs a member of the Government's GoGlobal Task Force, the HKTDC has established a dedicated GoGlobal Connect Zone at the Autumn Electronics Fair. This brings together professional service providers from the finance, legal, accounting and insurance sectors to assist businesses in areas such as financing, intellectual property, logistics, compliance and risk management, helping Chinese Mainland enterprises connect with international markets through Hong Kong’s professional services platform.The fair features a series of GoGlobal activities, including the "GoGlobal: Scaling Smart Consumer Innovations Worldwide" seminar at which representatives from Hang Seng Bank, the Hong Kong Export Credit Insurance Corporation and other industry and financial organisations will share insights on key strategies for overseas expansionThe fairs also feature a series of forums focusing on overseas market expansion. Representatives from OCBC Bank will share insights tomorrow afternoon (14 October) on the manufacturing ecosystem in the ASEAN bloc, helping companies interested in entering markets in these countries better understand the region's economic environment, tax regimes, market trends and business development opportunities.Over 120 robots highlight real-world applications of robotics technologiesThis year's Autumn Electronics Fair focuses on the latest consumer electronics products and innovative technologies under three highlighted themes: AI & Robotics, Smart Wellness and NEXTEntertainment. Related products are featured across different thematic zones throughout the exhibition. More than 120 robots are showcased at this year's fair, primarily within RoboPark, demonstrating applications across four key areas: Commercial & Services, Industrial & Logistics, Entertainment & Social, and Healthcare & Rehabilitation.Highlights include AgiBot Innovation (Shanghai) Technology Co., Ltd (Booth: 3CON-R31) and its full-sized humanoid robot Agibot A3; UBTECH (Booth: 3CON-R27), one of the "Shenzhen Eight Great Guardians", which is exhibiting its next-generation full-sized humanoid robot Walker C1, developed for urban coexistence; and DEEP Robotics (Booth: 3CON-R19), one of the "Hangzhou Six Little Dragons", displaying its quadruped robots Lite3 and M20.Other renowned exhibitors include the Shenzhen Honor Smart Technology Development Co., Ltd. (Booth: 3CON-R37), whose humanoid robot was the winner of the 2026 Beijing E-Town Half Marathon, and Booster Robotics (Booth: GH-R13), champion of the 2026 RoboCup. A number of well-known technology companies from the "Shenzhen Eight Great Guardians" and "Hangzhou Six Little Dragons" are also showcasing their latest innovations, including AI² Robotics (Booth: GH-Q01), Digit (Booth: 3CON-R49), EngineAI (Booth: 3CON-R52) and first-time exhibitor DexForce (Booth: GH-R07).The fair features several leading technology companies, including Booster Robotics (Booth: GH-R13), champion of the 2026 RoboCup, which showcases its latest innovations and technological achievementsRoboPark features multiple demonstration and experience zones, enabling buyers to explore how robotics technologies are being integrated into industries and everyday life. They include the RoboDog Garden, showcasing robotic dogs; the Robot Dance Battle, featuring dance performances by robots; and the Coffee & Popcorn Station, where robots prepare snacks and drinks, allowing visitors to experience the practical application potential of robotics at first hand.RoboPark features multiple interactive experience and demonstration zones. At the "Coffee & Popcorn Station", robots prepare snacks and drinks for visitorsNew products highlight AI integration across healthcare, lifestyle and entertainmentSmart Wellness encompasses digital health devices, smart wearables, personal care technologies, gerontech and healthy living electronics, reflecting strong market demand for technology-enabled health management and improved quality of life.Smart Wellness is another key focus of the Autumn Electronics Fair, with exhibitors showcasing innovative solutions ranging from digital health devices and smart wearables to personal care technologies, gerontech and healthy living electronics.Many exhibitors are leveraging the fair as a platform to showcase newly introduced products. Future Access Technology Co., Limited (Booth: 1C-D06) is presenting the LYRA, a screen-free smart wristband designed to minimise distractions and help users focus on daily life activities while supporting personalised fitness programmes and more than 170 sports modes. Cheung Shing Development (H.K.) Limited (Booth: 3D-E06) is displaying its latest Hearing Aid Glasses for people with mild to moderate hearing loss. Equipped with sound amplification technology, the glasses improve speech clarity in noisy environments and enhance communication experiences.NEXTEntertainment features extended reality (XR) technologies, smart gaming devices, digital content creation tools, AI-powered entertainment solutions and innovative consumer electronics designed to enhance both entertainment experiences and digital content creation. Among the highlights, DreamGear LLC (Booth: 1D-C09) is showcasing a new rechargeable retro gaming console featuring more than 200 built-in classic games, smart backlit button prompts and multiple control modes, combining nostalgic arcade gaming with modern innovation.The Autumn Electronics Fair features more than 20 exhibition zones. The Hall of Fame brings together over 560 renowned brands, including first-time exhibitors Aoni (Booth: 1A-D02) and HEAD (Booth: 1C-A12). RISE Avenue highlights emerging brands including Beijing Huahon Data Technology Co., Ltd. (Booth: 1CON-003), which is making its global debut with the All-in-One Liquid-Cooled AI Computing System, providing powerful computing capabilities for large-model training, AI inference and visual rendering through advanced liquid-cooling technology. The Adventure Hub features the Immersive Experience Zone, showcasing the latest applications of XR technologies, brain-computer interfaces and other creative technologies. Highlights include a brainwave-controlled claw machine from Yugu Technology (Booth: 5E-D12).Meanwhile, the Tech Hall focuses on AI, professional data and Internet of Things (IoT) solutions. Among the exhibitors, Guangzhou Quwan Network Technology Co., Ltd (Booth: CH-H10) is presenting the TemPolor Melo-D Generative AI Guitar, which integrates AI into music creation. Users simply upload their favourite songs and the system generates fingerstyle melodies while providing illuminated guidance on the guitar body and display screen to assist performance.More than 120 start-ups connecting with opportunitiesThe fairs also bring together more than 120 promising young enterprises and start-ups, primarily in the Startup Zone. The IOT HK Association Limited and JimHang Academy are each leading groups of start-ups showcasing technologies and solutions designed to address real-world business challenges. A range of supporting activities will also be held, including investment matching sessions, the Hong Kong Value Creation for Technology: Pitching Competition and mentorship programmes, helping start-ups refine their business models, expand investor networks and strengthen their market competitiveness.The fair brings together more than 120 promising young enterprises and start-ups, primarily showcased within the Startup ZoneelectronicAsia connects the electronics supply chainHeld concurrently with the Autumn Electronics Fair, electronicAsia (eAsia) features multiple thematic zones covering electronic components, display technologies, printed circuit boards and electronic manufacturing services, as well as testing and measurement instruments. Together, the two fairs create a comprehensive one-stop sourcing platform spanning the entire electronics industry supply chain.eAsia features a wide range of electronic components, display technologies, printed circuit boards, electronics manufacturing services and testing instruments, forming a one-stop sourcing platform together with the Autumn Electronics FairAmong the exhibitors at eAsia, Rapid Conn (S) Pte. Ltd. (Booth: 5B-C10) is showcasing advanced interconnect solutions, while Surface Mount Technology Ltd. (Booth: 5B-D01) is presenting cutting- edge AI and AIoT solutions.The fairs also feature a rich programme of forums and seminars. The 11th Symposium on Innovation & Technology, jointly organised by HKTDC and the Hong Kong Electronics and Technologies Association, takes place today under the theme "AI-Driven Security & The Next-Gen Infrastructure". Speakers include Alexander Gerfer, Chief Technology Officer of Würth Elektronik Group; Dr Charles Cheung, Adjunct Associate Professor in the Department of Mathematics at Hong Kong Baptist University; and Silvia Ihensekhien, Chief Security Advisor, Greater China at Microsoft.The Symposium on Innovation & Technology, jointly organised by HKTDC and the Hong Kong Electronics and Technologies Association, takes place today under the theme "AI-Driven Security & The Next-Gen Infrastructure"In addition, the Hong Kong Electronic Forum, jointly organised by the HKTDC, MMI Asia Pte Ltd and the Hong Kong Electronic Industries Association, with support from the Electronics Division of The Hong Kong Institution of Engineers, will be held on 15 October under the theme "Future Tech: Powering Electronics Competitiveness with AI and Sustainable Innovation", exploring how AI, sustainability and technological innovation are reshaping the future of the electronics sector.Under the EXHIBITION+ hybrid model, exhibitors and buyers can meet online through the HKTDC Click2Match smart business matching platform in addition to attending the physical fairs. The online exhibitions for the Hong Kong Electronics Fair (Autumn Edition) and electronicAsia run from 6 to 23 October.Photo download: https://bit.ly/4AVhNOuWebsites- Hong Kong Electronics Fair (Autumn Edition): https://www.hktdc.com/event/hkelectronicsfairae/en- electronicAsia: https://www.hktdc.com/event/electronicasia/enMedia enquiriesPlease contact the HKTDC’s Communications & Public Affairs Department:Katy WongTel: (852) 2584 4524Email: katy.ky.wong@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgHKTDC Media Room: https://mediaroom.hktdc.com/enAbout HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via trade publications, research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

NEW YORK, Oct 13, 2026 - (ACN Newswire via SeaPRwire.com) - ADK Holdings Inc. (Headquarters: Minato-ku, Tokyo; Representative Director and President: Toshiya Oyama) has entered into a Master Agreement for a three-year strategic business partnership with Stagwell Inc. (Headquarters: New York, USA; Chairman & CEO: Mark Penn; hereinafter "Stagwell" (NASDAQ:STGW)).This partnership aims to maximize the value delivered to clients in both the Japanese and global markets by leveraging the complementary capabilities and global networks of the two companies.By combining the comprehensive capabilities and trust that the four core ADK Group companies (ADK Holdings, ADK Marketing Solutions, ADK Creative One, and ADK Emotions) have cultivated in the Japanese market over many years with Stagwell's marketing service capabilities powered by world-class technology and its global network, the two companies will fully launch a comprehensive support framework to solve clients' marketing challenges in Japan and around the world.From One Year of Collaboration to a Three-Year Strategic Business PartnershipUnder the Memorandum of Understanding on promoting global collaboration signed in July 2025, the two companies have spent approximately one year validating the effectiveness of their collaboration through a variety of joint projects. These efforts have produced results across multiple areas, including supporting the global expansion of IP originating in Japan and helping major Japanese corporate clients expand overseas.The signing of this Master Agreement marks a formal transition from the previous project-based cooperation to a stable, three-year strategic collaboration framework.Key Focus Areas for CollaborationWith the signing of the Master Agreement, the two companies have designated the following two areas as key focus themes for their collaboration.Expanding IP business in global markets, starting with the United StatesBy combining ADK's global IP production capabilities, grounded in its marketing expertise, with Stagwell's U.S. entertainment data and analytics capabilities and comprehensive marketing execution capabilities, the two companies will drive, end to end, the North American expansion of Japanese IP and the creation of joint businesses in Japan and overseas.Strengthening support for global and multinational brands in the Japanese marketWorking with the global network of Stagwell, which has numerous highly specialized marketing companies under its umbrella, the two companies will build optimal solutions and support structures to help multinational brands enter and grow their businesses in the Japanese market.Ongoing Areas of CollaborationSupporting Japanese companies' marketing activities targeting global marketsEnhancing services in Japan and overseas through the shared use of both groups' data assets, tools, and solutionsIn addition, by mutually assigning resources in the target areas and promoting ongoing exchanges of personnel, the two companies aim to build a strong alliance at both the organizational and personnel levels and to advance this strategic business partnership with a high degree of effectiveness.Comment from Masato Suematsu, Executive Officer, Global Marketing, ADK Marketing Solutions"Since signing the MOU in 2025, our two companies have validated the effectiveness of our collaboration through joint projects and steadily built a solid track record of cooperation both in Japan and overseas. Based on the confidence gained over the past year, we are delighted to upgrade our partnership into a more powerful strategic collaboration framework. Moving forward, we will deeply integrate Stagwell's global network, cutting-edge technology, and data analytics capabilities with ADK's essential expertise in identifying and solving core challenges. This will enable us to provide even stronger support for the global expansion of Japanese IP - starting with North America - and the overseas expansion of Japanese companies, while comprehensively supporting global brands in achieving success in the Japanese market. We are confident that this partnership will bring unprecedented new value to our clients and contribute to the steady growth and development of their businesses."Comment from Randy Duax, Managing Director, Stagwell Asia-Pacific"What sets this partnership apart from most industry announcements is that we've already spent a year proving it works. ADK brings an unmatched understanding of Japan, its consumers and its IP ecosystem, while Stagwell brings a global network built to transform marketing through AI, connecting world-class talent with technology, data and specialist expertise. Together, we have a unique ability to help Japanese brands and IP become truly global, while helping the world's leading brands win in Japan. We've built the foundation. Now we're ready to scale."About StagwellStagwell is the global challenger network transforming marketing through AI. We deliver scaled creative performance for the world's most ambitious brands, connecting culture-moving creativity with leading-edge technology to harmonize the art and science of marketing. Led by entrepreneurs, our specialists in 40+ countries are unified under a single purpose: to drive effectiveness and improve business results for our clients. Join us at www.stagwellglobal.com.About ADK GroupADK Group consists of the pure holding company ADK Holdings Inc. and three operating companies under it, ADK Marketing Solutions, ADK Creative One, and ADK Emotions, each established to enhance specialized expertise. Under its business vision "Growing Brands and Fans," the Group aims to continue contributing to the sustainable growth of its clients' businesses by creating fans, deepening bonds with fans, and generating new value together with fans.ADK Holdings website https://www.adk.jp/About the four core ADK Group companies: https://www.adk.jp/en/about/outline/Contacts for This ReleaseADK Marketing Solutions Inc.Business Development Division, Global Projects Suematsu / Takedae-mail: adk-global_prj@adk.jpADK Holdings Inc.PR & Marketing Group, Public Relations Office, Corporate Planning Division Uchiyama / Saitoe-mail: mspr@adk.jpSOURCE: Stagwell Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

NAPERVILLE, IL, Oct 12, 2026 - (ACN Newswire via SeaPRwire.com) - Charlie Harte joins Chervon as Director of Field Sales and Recruiting - Canada, effective Monday, October 12, 2026, reporting to Neil Harrison, VP/MD Sales and Marketing - Canada.Harte brings 15+ years of experience in the Canadian power tools, outdoor power equipment, and hand tool market. Additionally, he has 6+ years of experience selling into the commercial plumbing arena.Early in his career, Harte spent six years at Black and Decker growing into the National Sales and Marketing Manager position for B&D Canada. He subsequently became Director of Sales for Irwin Industrial Tools and then became a Director of Sales for Milwaukee Canada. Harte moved into the VP Sales position for Uponor Advanced Plumbing Solutions.Harte has an impressive track record in field sales leadership and strategic account development. He is known for his ability to build and manage high-performance sales teams throughout Canada."Charlie brings an outstanding skillset to Chervon Canada," said Neil Harrison, VP/MD Canada. "His strength in sales management and in creating and mentoring high potential sales talent will accelerate our growth in the Canadian market.""I feel I have been preparing for this exciting role at Chervon my entire career," said Harte. "I look forward to working with our amazing Canadian team in building the leading pro power tool and outdoor power equipment company in our market."Harte earned his undergraduate degree in business at Polytechnic of Wales, UK. He then studied international business at Xi'an Jiaotong-Liverpool University in Suzhou, China. He then completed his MBA at the University of Toronto.ABOUT CHERVONChervon North America is part of a global total solution provider specializing in R&D, manufacturing, testing, sales, and after-sales service of power tools and outdoor power equipment (OPE). Guided by user-centric innovation, the Company operates an integrated business model supported by global sales and distribution networks. Chervon's portfolio includes EGO, FLEX, SKIL, and DEVON, servingindustri al, professional, and consumer markets globally.Better Tools. Better World.Chervon is committed to delivering superior products to users worldwide through continuous innovation and strives to become a global leader in power tools and OPE in the lithium-ion, intelligent, and digital era.PR Contact:Corporate Communications: CorpComm@na.chervongroup.comSOURCE: Chervon Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

NAPERVILLE, IL, Oct 12, 2026 - (ACN Newswire via SeaPRwire.com) - Randy Durkan joins Chervon as Vice President of Supply Chain - North America, effective Monday, October 12, 2026, reporting to CEO Joe Galli.Randy Durkan brings over 25 years of supply chain management experience, including extensive leadership in power tools, hand tools, and outdoor power equipment. He has proven experience building high-performance supply chain teams and has consistently delivered outstanding service levels, inventory optimization, and cost-reduction results. Durkan is known for developing strong supply chain partnerships with key customers, driving cross-functional collaboration, and deploying technology to achieve world-class supply chain performance.He began his early supply chain career in Bentonville, Arkansas, supporting Walmart-focused collaboration across several consumer goods companies. His work at Vi-Jon contributed to Walmart's 2008 Supplier of the Year Award.Durkan then spent six years in supply chain management consulting with Hitachi Consulting, traveling worldwide to help clients improve their supply chain performance. In 2019, Randy joined TTI as SVP of Supply Chain for Consumer Products & Outdoor Power Equipment, where he again delivered supplier of the year award level performance.Most recently, Durkan served as Vice President of Sales, Inventory, and Operations Planning (SIOP) for the Apex Tool Group.Durkan holds a B.S. in Business Logistics & International Business from Penn State University. He is also a graduate of the TTI Breakthrough Leadership Program and is Certified in Production & Inventory Management through APICS."We are highly fortunate to have Randy joining Chervon as VP of Supply Chain for North America," said CEO Joe Galli. "His world-class supply chain management skills, transformative AI integration capabilities, and customer obsession will help us take our company to the next level.""Chervon's customer service and growth focus align perfectly with my experience and skill set," said Durkan. "I look forward to helping Chervon exceed customer expectations through supply chain excellence, high-performance teamwork, and AI integration."ABOUT CHERVONChervon North America is part of a global total solution provider specializing in R&D, manufacturing, testing, sales, and after-sales service of power tools and outdoor power equipment (OPE). Guided by user-centric innovation, the Company operates an integrated business model supported by global sales and distribution networks. Chervon's portfolio includes EGO, FLEX, SKIL, and DEVON, serving industrial, professional, and consumer markets globally.Better Tools. Better World.Chervon is committed to delivering superior products to users worldwide through continuous innovation and strives to become a global leader in power tools and OPE in the lithium-ion, intelligent, and digital era.PR Contact:Corporate Communications: CorpComm@na.chervongroup.comSOURCE: Chervon Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

NAPERVILLE, IL, Oct 12, 2026 - (ACN Newswire via SeaPRwire.com) - Thomas G. Kentouris joins Chervon as Vice President of Field Sales, effective Monday, October 12, 2026, reporting to Matt DeFeo, SVP of Sales Training and Recruiting.Kentouris brings 14+ years of Power Tool and Outdoor Power Equipment experience at TTI. His career began as a sales rep and advanced through a series of increasingly responsible positions, culminating in SVP of Field Sales for Eastern U.S.A.Kentouris delivered exceptional sales growth results year after year in his areas of responsibility. His ability to develop store-level partnerships and store-level sell-through programs all resulted in exceptional levels of success.Kentouris distinguished himself as an outstanding recruiting talent as he and his teams were responsible for recruiting over 2,000 high potential recent college graduates into the TTI system. Kentouris did an amazing job mentoring, developing, and promoting hundreds of his people into higher level positions throughout the company."Kentouris' powerful, inspiring leadership skills combined with his unmatched drive and work ethic all make him a super star level talent for Chervon," said SVP Matt DeFeo. "Thomas will have an immediate and lasting impact on Chervon's results.""I am thrilled to join Chervon and look forward to immediately beginning to build and mentor high-performance sales teams," said Kentouris. "I feel the skills I have developed match up perfectly with our bold plans of perpetual future growth."Kentouris earned his degree in Marketing from York College in Pennsylvania. He is also a graduate of the TTI breakthrough leadership program.ABOUT CHERVONChervon North America is part of a global total solution provider specializing in R&D, manufacturing, testing, sales, and after-sales service of power tools and outdoor power equipment (OPE). Guided by user-centric innovation, the Company operates an integrated business model supported by global sales and distribution networks. Chervon's portfolio includes EGO, FLEX, SKIL, and DEVON, serving industrial, professional, and consumer markets globally.Better Tools. Better World.Chervon is committed to delivering superior products to users worldwide through continuous innovation and strives to become a global leader in power tools and OPE in the lithium-ion, intelligent, and digital era.PR Contact:Corporate Communications: CorpComm@na.chervongroup.comSOURCE: Chervon Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Hong Kong, Oct 12, 2026 - (ACN Newswire via SeaPRwire.com) - The International Congress of Parkinson's Disease and Movement Disorders (MDS 2026) was held in Seoul, South Korea, from October 4 to 8, 2026. Micot Pharma (2335.HK) presented, for the first time in an electronic poster, nonclinical findings in Huntington's disease (HD) and Phase I clinical results in healthy volunteers for its independently developed drug candidate MT200605. Together with previously announced positive Phase II data in acute ischemic stroke (AIS), these findings are beginning to establish a development path for this small-molecule tropomyosin receptor kinase B (TrkB) agonist from acute brain injury to neurodegenerative diseases.On-site photo from the MDS 2026 CongressOrganized by the International Parkinson and Movement Disorder Society, the MDS Congress is one of the largest and most influential international scientific meetings in the field. The selection of MT200605's Huntington's disease research for presentation signals recognition by the international scientific community of its clinical value in neurodegenerative diseases.For Micot Pharma, the significance of this appearance extends beyond the poster presentation itself. It brings MT200605's progress in clinical development for stroke into an international forum for scientific exchange on movement disorders and neurodegenerative diseases. It also gives the market a more complete view of the development program: animal-model findings and Phase I data in healthy volunteers are available for the HD program, Phase II topline results are available for AIS, and the TrkB mechanism provides the central link between research in acute brain injury and chronic neurodegenerative diseases.On-site photo from the MDS 2026 CongressMT200605 Explores Disease-Modifying Potential in Huntington's Disease through Motor Improvement and Preservation of Brain StructureHuntington's disease is an inherited, progressive neurodegenerative disorder. Patients gradually develop chorea, cognitive decline, and psychiatric and behavioral disturbances, eventually becoming fully dependent on care. Current treatments primarily manage symptoms; no treatment can yet halt or reverse disease progression. Protecting neurons and preserving neurological function are therefore important areas of research.The publicly available MDS 2026 abstract reports that MT200605 improved motor coordination and attenuated whole-brain, cortical, and striatal atrophy in transgenic HD mice. The study also found that levels of the striatal neuronal marker DARPP-32 were maintained and that aggregation of mutant huntingtin protein (mHTT) in the cortex was reduced. In vitro experiments showed activation of TrkB and downstream AKT signaling, as well as enhanced mitochondrial adenosine triphosphate (ATP) production in HD cells.The value of these findings lies in the converging evidence from behavioral, imaging, and cellular pathology measures. Beyond improved motor performance, changes in brain atrophy and aggregation of the disease-causing protein provide a more concrete basis for investigating a potential disease-modifying effect.The poster also presented results from a Phase I clinical study of MT200605 in healthy adults. The study used a single-center, randomized, double-blind, placebo-controlled design and comprised single ascending dose (SAD) and multiple ascending dose (MAD) stages.No serious adverse events, deaths, or withdrawals due to adverse events were reported. Drug-related adverse events were all mild and self-limiting. Pharmacokinetic results showed that drug exposure increased with dose, with no appreciable accumulation after multiple doses and an overall predictable pharmacokinetic profile. These results provide a safety and pharmacokinetic foundation for subsequent clinical studies in patient populations.TrkB Signaling Provides a Basis for Extending Development from Acute Brain Injury to Neurodegenerative DiseasesA defining feature of MT200605's mechanism is its pharmacological modulation of the brain-derived neurotrophic factor (BDNF)/TrkB neurotrophic signaling pathway. This pathway contributes to neuronal survival, synaptic maintenance, and mitochondrial stability, providing an important biological basis for neuroprotection and the preservation of function.MT200605's pharmacological design reportedly combines agonism of the BDNF/TrkB pathway with attenuation of oxidative stress and relief of microcirculatory impairment caused by calcium ion-induced contraction of vascular smooth muscle. The development rationale is to explore more comprehensive neuroprotection by intervening in multiple components of the injury process.From a mechanistic perspective, targeting TrkB provides a rationale for extending MT200605's development into chronic neurodegenerative diseases. Although the pathogenic processes of stroke and Huntington's disease differ substantially, neuronal injury, loss of function, and insufficient neurotrophic support offer points of entry for research across diseases. The findings across multiple measures in the HD model provide new experimental support for this direction.Positive Phase II Stroke Results Show a Significant Reduction in Disability and Potential for Renal ProtectionMT200605 has completed a Phase II clinical trial in acute ischemic stroke. The multicenter, randomized, double-blind, placebo-controlled study enrolled 360 participants. The primary efficacy endpoint was the proportion of patients achieving a modified Rankin Scale (mRS) score of 0-1 at 90 days after stroke onset.Results disclosed by the company show that the proportions of patients achieving favorable functional outcomes in both the medium- and high-dose groups were higher than in the placebo group, demonstrating a treatment advantage rarely seen among drugs in this class. For the high-dose group, achieving an mRS score of 0-1 corresponded to an increase of more than 100% in the odds of functional recovery versus placebo, as reflected by the odds ratio (OR). In terms of clinical benefit, approximately one additional patient moved from "requiring assistance" to "being able to live largely independently" for every six patients treated. Over decades of neuroprotective drug development, agents demonstrating such a marked difference in functional outcomes versus placebo in a randomized controlled trial have been exceptionally rare. The difference between the high-dose group and placebo was statistically significant, and the study showed a clear dose-response relationship. The study also observed a trend toward early neurological recovery in the high-dose group, with no serious adverse events related to the investigational drug.For stroke-associated acute kidney injury (AKI), the study also observed a trend toward a dose-dependent reduction in incidence, providing exploratory clinical evidence for further research into the mechanism of "dual brain and kidney protection." The design rationale for this dual protection was validated in the Phase II trial: MT200605 significantly reduced disability and showed the potential to lower AKI incidence in patients with AIS in a dose-dependent manner. AKI incidence in the high-dose group was more than 80% lower than in the placebo group. This result addresses the existing therapeutic gap in preventing AKI in patients with AIS.Neurological Recovery and Combined Brain and Kidney Protection Offer the Potential to Fill a Therapeutic GapCurrently, no neuroprotective drug for AIS has a Class I recommendation supported by Level A evidence in Chinese clinical guidelines. Most marketed agents have Class II recommendations supported by Level B evidence.Mainstream neuroprotective drugs in China include butylphthalide, edaravone, and edaravone dexborneol. Their mechanisms are generally limited to blocking injury through one or two targets, without a mechanistic design that simultaneously promotes neural repair, and none has demonstrated a statistically significant difference in long-term functional outcomes such as those measured by the mRS.Butylphthalide has a research foundation in neuroprotection involving multiple targets. The randomized BAST trial enrolled 1,216 patients with acute ischemic stroke who received intravenous thrombolysis and/or endovascular treatment. Favorable functional outcomes at 90 days were achieved by 56.7% of patients in the butylphthalide group and 44.0% in the placebo group. The endpoint used different mRS thresholds according to baseline stroke severity, providing evidence for combining neuroprotection with reperfusion treatment.Edaravone's principal pharmacological action is free radical scavenging, while edaravone dexborneol extends antioxidant and anti-inflammatory intervention through a combination formulation. In the Phase III TASTE study involving 1,165 patients, the proportions achieving an mRS score of ≤1 at 90 days were 67.18% in the edaravone dexborneol group and 58.97% in the edaravone group. Edaravone dexborneol was superior to edaravone, with a statistically significant difference.The research indicates that MT200605's differentiation should not be reduced to a simple numerical comparison of efficacy with existing agents. The more relevant question to follow is whether the TrkB neurotrophic pathway can translate the functional outcome signals observed in patients with AIS into clinical benefits in chronic neurodegenerative diseases. As a first-in-class (FIC) investigational drug, MT200605 has completed clinical proof of concept. Its effect size far exceeds that of other neuroprotective agents, and it has the potential to become the first treatment in this field to receive high-level recommendations as a first-line option in both Chinese and international clinical guidelines.Another "silent killer" can emerge following stroke: acute kidney injury (AKI).Approximately 19% of patients with AIS develop AKI, and the risk of in-hospital death among patients with AKI is around two to three times that of patients without AKI. Product labeling for approved mainstream neuroprotective drugs advises caution or contraindicates use in patients with impaired renal function or severe renal failure. As a result, precisely those stroke patients facing a higher risk of death are excluded from treatment.A further reason to follow MT200605 is that, alongside the positive signals for 90-day functional outcomes in the AIS Phase II trial, the company has disclosed a new area of investigation: renal protection after stroke. According to Micot Pharma's announcement, AKI incidence in the high-dose group was approximately 80% lower than with placebo in the Phase II data. This means that MT200605 is currently the world's only investigational neuroprotective drug with the potential to specifically prevent and treat post-stroke AKI, and the only agent in this class that could potentially be approved and used with a "renal protection" claim in its labeling.MT200605's ability to protect both the brain and kidneys is closely linked to its distinctive mechanism of action.TrkB receptors are expressed not only in brain tissue but also in renal podocytes, renal tubular epithelial cells, and the juxtaglomerular apparatus. Their activation can stabilize the podocyte cytoskeleton, inhibit renal tubular epithelial cell apoptosis by counteracting endoplasmic reticulum stress through PI3K/AKT signaling, and activate antioxidant defenses through the nuclear translocation of nuclear factor erythroid 2-related factor 2 (NRF2), an important target of neuroprotective drugs.A single molecule protects two organs affected by stroke. The protective pathways in the brain and kidneys share the core PI3K/AKT signaling cascade, disrupting at its origin the vicious cycle of brain injury leading to AKI, worsening renal function, and further aggravation of brain injury.The MDS presentation and AIS Phase II topline results are therefore complementary. The former expands MT200605's international scientific visibility and the scope of its HD research, while the latter provides a translational foundation in patient functional outcomes. For a biopharmaceutical company focused on innovative medicines, a development program built around one mechanism, multiple disease settings, and progressively accumulating evidence at different levels often has greater scope for expansion than an early-stage narrative centered on a single indication.ConclusionIn the near term, MDS 2026 has given Micot Pharma an international platform to present its research in movement disorders. Over the medium to long term, the program's value as a platform will depend on whether the company can continue to use verifiable clinical data to translate the potential of the TrkB mechanism across different disease settings into benefits for patients. For the capital markets, this is the central rationale for continuing to follow MT200605's development. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Hong Kong, Oct 12, 2026 - (ACN Newswire via SeaPRwire.com) - Changzhou Microintelligence Co., Ltd (“Microintelligence” or “the Company”) recently passed the hearing of the Listing Committee of The Stock Exchange of Hong Kong Limited (HKEX) on X 2026. Orient Capital, the subsidiary of Orient Securities, is the sole sponsor for the initial public offering. Based on 2025 revenue, the Company is China’s largest supplier of Embodied Industrial Intelligent Robots (EIIR), with a market share of approximately 20.0%.Microintelligence was founded in 2018. As a leader in industrial embodied intelligence, the Company develops EIIR products and integrated solutions capable of autonomous perception, learning, decision-making and executing of complex tasks with its full-stack self-developed software, hardware and systems engineering capabilities. Its products have achieved commercialization at scale in real-world industrial settings, including in industries with extremely high requirements for precision, stability, and reliability, such as 3C electronics, automotive manufacturing, new energy, fast-moving consumer goods (FMCG), and semiconductors. Meanwhile, its application scenarios are evolving from "mature single-process workflow” to "integrated workstations." According to IDC's China Industrial Embodied Intelligent Robots Market Share, 2025 report, the company holds the No. 1 market share in China. The Company is also one of the world’s first leading companies to achieve commercial verification of embodied industrial intelligence robots in multiple complex industrial scenarios.Through a standardized "Cloud-Edge-Device" integrated architecture, Microintelligence combines AI models, industrial know-how, and real-world scenario data to build core physical AI capabilities. This enables EIIR to complete a fully autonomous closed loop spanning perception, learning, decision-making, and execution. As EIIR systems roll out across real factory environments, the company has also built a "data-model-product-redeployment" flywheel. On-site data accumulated during production line operations is distilled into process knowledge through a "human-in-the-loop" mechanism with insights fed back into ongoing model iteration. As model capabilities advance, the products can take on more complex production tasks and continue to broaden their application scope. Backed by full-stack software and hardware capabilities and commercial validation in real-world scenarios, the company has delivered efficient, cost-effective commercialization across multiple industrial scenarios, creating a durable competitive moat.Through the continuous deployment of the aforementioned technologies and industrial practices, the Company has been accumulating real production-line industrial data while maintaining high levels of R&D investment. According to the documents disclosed after its hearing, the Company amassed an unstructured, finely-annotated database sourced from real industrial scenarios, with a data volume exceeding 23TB and containing over 1.6 billion annotated data records. The database holds more than 800 independent intellectual property rights, including over 210 invention patents and 310 software copyrights. In 2024, the Company’s R&D project entitled “Development and Application of High-Speed, Self-Planning, Integrated Intelligent System for Defect Detection and Repair” has been jointly certified by the Ministry of Industry and Information Technology (MIIT) and the Ministry of Science and Technology (MOST) as having reached an “International Leading” level. The Company’s client base includes more than 25 Fortune Global 500 enterprises and leading manufacturers. Its business spans mainland China, Europe and the United States, and actively develops for the expansion into new overseas markets including Japan, Singapore and Malaysia.Financially, the Company’s revenue rose from RMB 434 million in 2023 to RMB 796 million in 2025, representing a compound annual growth rate (CAGR) of 35.4%. For the five months ended May 31, 2026, the Company recorded revenue of RMB 424 million, up 22.6% year on year. Revenue from its flagship EIIR products grew from RMB 114 million in 2023 to RMB 453 million in 2025, and reached RMB 260 million for the five months ended May 31, 2026. The EIIR products’ contribution to total revenue rose to 61.4% for the five months ended May 31, 2026, while gross margin further improved to 54.8%.In terms of profitability, the Company achieved profitable results for two consecutive years in 2024 and 2025. It recorded a full-year profit of approximately RMB 15.7 million in 2024 and approximately RMB 5.1 million in 2025, as higher R&D investment weighed on profit for the year. For the five months ended May 31, 2026, profit reached RMB 22.53 million, while adjusted net profit for the period—excluding the impact of share-based payments and listing expenses—amounted to RMB 33.84 million, up 41.5% year on year. In addition, following the turnaround to positive operating cash flow in 2025, the Company continued to record net cash inflow for the five months ended May 31, 2026, reflecting a substantive and sustained improvement in the cash-generating capability of its core business.The Company plans to primarily allocate the proceeds from this initial public offering to core technology R&D, focusing on iterating the Company’s end-to-end industrial VLA model, to continuously enhance the intelligence and performance of EIIR robots. In parallel, the Company will build localized overseas sales and service networks to deepen its global business footprint. In addition, the Company will allocate the proceeds for strategic investments and to foster an open, win-win application ecosystem through M&A, to expand manufacturing capacity to meet the growing order volumes.Looking ahead, Microintelligence will seize the opportunity presented by its HKEX listing to continue to strengthen its core capabilities in industrial embodied intelligence. As the global manufacturing sector continues to advance its intelligent transformation, the Company will focus on six key dimensions—deepening customer engagement, replicating success across new industries, expanding overseas, upgrading product value, strengthening software-hardware synergies, and driving continuous AI evolution—to bring EIIR solutions into more industrial scenarios. Together with industry partners, the Company will build an industrial embodied intelligence ecosystem and create long-term value for customers and the industry as a whole. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

BALI, INDONESIA, Oct 12, 2026 - (ACN Newswire via SeaPRwire.com) - The Indonesian Government brought together delegates from 35 countries, international organizations, collective management organizations, creators, industry representatives, and experts to discuss cross-border copyright royalty governance in the digital era. The Global Dialogue on Cross-Border Copyright Royalty Governance in the Digital Era is being held in Bali from October 7 to 9, 2026, focusing on three key issues: transparency, accountability, and system interoperability.Doc. Participants at the Global Dialogue on Cross-Border Copyright Royalty Governance in the Digital Era.“Through the Global Dialogue on Cross-Border Copyright Royalty Governance in the Digital Era, we seek to promote common rules and systems so that copyright royalties, which are increasingly flowing across national borders, can be recorded, calculated, and distributed in a more transparent, accountable, and fair manner,” said Indonesian Minister of Law Supratman Andi Agta.The dialogue, initiated by the Indonesian Government through the Directorate General of Intellectual Property (DJKI), is being held from October 7 to 9, 2026. A total of 35 countries are actively participating in the forum, both online and in person, bringing together member states of the World Intellectual Property Organization (WIPO), two intergovernmental organizations, six collective management organizations and industry representatives, as well as experts, creators, and other stakeholders.“When creative works can be enjoyed across countries through digital platforms, royalty governance must also keep pace with these developments. Transparency, accountability, and interconnected systems are essential to ensure that creators’ economic rights are protected,” he said.Supratman said cross-border royalty issues go beyond copyright regulations, also requiring coordination among institutions and interoperable information systems. Against this backdrop, Indonesia is pushing for international dialogue to share experiences and practices across countries while respecting each nation’s legal framework.“This forum provides a platform for building a shared understanding and exploring practical cooperation. The goal is to ensure that creators and rights holders receive a fairer share of the economic benefits generated from the use of their works in the digital environment,” he said.Director General of Intellectual Property at the Ministry of Law Hermansyah Siregar said cross-border royalty issues are largely related to information exchange rather than copyright law itself. Incomplete ownership data, metadata, and differences in systems can complicate efforts to match the use of creative works with their respective rights holders.“Cross-border royalty friction rarely stems from disputes over copyright law. The main challenge is the exchange of information,” Hermansyah saidAccording to Hermansyah, these challenges can arise at every stage, from work registration and usage reporting to metadata matching that links usage reports to rights holders. When unique identifiers for creative works are unavailable, royalty calculation, distribution, and reconciliation become increasingly complex.Data from the International Confederation of Societies of Authors and Composers (CISAC) showed that global royalty collections by creators’ rights organizations reached €13.97 billion (approximately Rp278 trillion) in 2024. Of that amount, €5.14 billion (approximately Rp103.16 trillion), or around 37 percent, came from digital uses. However, royalty collections remain concentrated in Europe and North America.The dialogue focuses on three key issues: transparency, accountability, and system interoperability. Transparency concerns the information available to rights holders; accountability covers responsibility at every stage of royalty management; while interoperability refers to the ability of different systems to exchange information reliably.At the international level, WIPO is also promoting good governance in collective management through publications and technical assistance, including guidance on good practices for collective management organizations and the TAG of Excellence initiative on transparency, accountability, and governance. These efforts are expected to be developed in collaboration with stakeholders, while applying professional rules and governance standards across member organizations.In Indonesia, the copyright framework is governed by Law No. 28 of 2014 on Copyright, which also establishes the national framework for collective management. In addition, Government Regulation No. 56 of 2021 on the Management of Copyright Royalties for Songs and/or Music provides a framework for the collection and distribution of royalties. The regulation also provides for a centralized database of songs and music managed by the Directorate General of Intellectual Property, as well as the Song and/or Music Information System (SILM), which supports the registration of works, usage data, and royalty distribution.According to Hermansyah, system interoperability is key to ensuring that royalties can flow from the use of a work through to its rights holder. Indonesia is also developing the Song and Music Data Center (PDLM) and information systems to establish connectivity with global royalty systems.“Interoperability simply requires systems that can communicate reliably. Many emerging markets currently lack the IT infrastructure needed to process large volumes of digital data,” he said.Indonesia has previously put forward a proposal on royalty governance, known as the Indonesian Proposal, at the World Intellectual Property Organization’s (WIPO) Standing Committee on Copyright and Related Rights (SCCR). Discussions on the proposal will continue at the SCCR, while the Global Dialogue in Bali provides a platform for sharing experiences and identifying practical solutions that can be developed on a voluntary basis. “Technology has democratized the distribution of music. Our task now is to ensure that our governance structures democratize remuneration for those works as well,” Hermansyah said.About DJKIThe Directorate General of Intellectual Property (DJKI) is an echelon I unit under the Ministry of Law of the Republic of Indonesia, responsible for formulating and implementing policies in the field of intellectual property.DJKI provides registration and protection services for copyrights, patents, trademarks, industrial designs, geographical indications, integrated circuit layout designs, and trade secrets. Through digital transformation and strengthened public services, DJKI is committed to providing fast, transparent, and accountable legal protection for creators, inventors, and businesses across Indonesia.Directorate General of Intellectual Property (DJKI) – Public RelationsMinistry of Law of the Republic of IndonesiaDJKI BuildingJl. HR. Rasuna Said Kav. 8–9, South Jakarta, Jakarta, IndonesiaM. Wahdan H.J.Q.+62 878-3954-6154 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

MIAMI, FL, Oct 9, 2026 - (ACN Newswire via SeaPRwire.com) - Miami Fashion Week® (MIAFW) celebrates its 10th anniversary this year, returning October 13-18, 2026 featuring industry programming, runway shows, and special events bringing together international designers, Latin American talent and Miami's creative community. For a decade, MIAFW has served as a bridge between Miami and the international fashion industry, creating a platform for designers while expanding beyond the runway through sustainability, technology, education and cultural exchange.The milestone edition brings together international designers, Latin American talent, fashion innovation and a new Stitch Lab retail experienceThroughout these ten years, MIAFW has pioneered initiatives at the intersection of fashion, sustainability and technology. Founded in 2017, the MIAFW Summit created a space for dialogue and education around the industry's evolving challenges and opportunities. Building on that vision, the Virtual Fashion Awards, launched in May 2026, opened a new chapter in digital creativity and innovation. This anniversary edition will bring that vision to the runway, with competition winner Jhoan Sebastian Grey presenting his collection in a runway show awarded as part of his prize."Celebrating 10 years of Miami Fashion Week is an incredibly meaningful milestone," says Lourdes Fernandez-Velasco, Executive Director of Miami Fashion Week. "Over the past decade, we've built a platform that connects designers, creatives and industry leaders from around the world while remaining deeply rooted in Miami. In recent years, the continued institutional support of Miami-Dade County, now for the fourth consecutive year, alongside the support of the City of Miami Beach and our partnership with Miami Dade College, has been instrumental in strengthening that foundation and expanding our impact. This year is both a celebration of how far we've come and an exciting look at where fashion is going next."The anniversary edition will bring fashion into focus across the city, from runway presentations throughout Miami and the MIAFW Summit in partnership with the Miami Fashion Institute to the annual Miami Fashion Week Gala. Making its debut this year, a collaboration with Stitch Lab will introduce MIAFW's first shopping experience: a three-day pop-up on Miracle Mile in Coral Gables, featuring more than 20 brands and giving consumers the opportunity to discover and shop participating labels. Together, these experiences celebrate Miami as a meeting point for fashion, culture and creativity, connecting established industry voices with emerging talent, students and the wider community.Program HighlightsTues., Oct. 13Press Conference - 9:30 AM | Freedom Tower at Miami Dade College Speakers include: City of Miami Beach Mayor Steven Meiner, City of Coral Gables Mayor Vince Lago, Commissioner Oliver Gilbert, Miami Dade College President Madeline Pumariega, and Andres Otalora (fashion designer).Designers will be in attendance and available for interviews.Miami Fashion Week Gala featuring Andres Otalora, with a special performance by Latin Grammy-winner Joaquina - 6:00 PM | Queen Miami BeachThis is a ticketed event benefiting Miami Dade College's Miami Fashion Institute.Wed., Oct. 14MIAFW Summit with the Miami Fashion Institute - 12:00-6:00 PM | Miami Dade College Wolfson CampusThe annual Summit brings together fashion leaders, creatives and innovators for conversations exploring the future of fashion, technology, sustainability and digital innovation. The Summit will be followed by a cocktail reception.Thurs., Oct. 15Jenny Polanco Fashion Show - 3:00 PM | Mr. C Coconut GroveMIAFW x Stitch Lab, Presented and Hosted by Terranova - 6:30 PM | 350 Miracle Mile, Coral GablesFri., Oct. 16MIAFW x Stitch Lab Pop Up - 10:00 AM - 6:00 PM | 350 Miracle Mile, Coral GablesJacqueline Then Fashion Show - 5:30 PM | Freedom Tower at Miami Dade CollegeGiannina Azar Fashion Show - 7:00 PM | Freedom Tower at Miami Dade CollegeJhoan Sebastian Grey Fashion Show - 8:30 PM | Freedom Tower at Miami Dade CollegeSat., Oct. 17MIAFW x Stitch Lab Pop Up - 10:00 AM - 6:00 PM | 350 Miracle Mile, Coral GablesVero Diaz Fashion Show - 5:30 PM | Freedom Tower at Miami Dade CollegeYenny Bastida Fashion Show - 7:00 PM | Freedom Tower at Miami Dade CollegeEfraín Mogollón Fashion Show - 8:30 PM | Freedom Tower at Miami Dade CollegeClosing Party - 09:00 PMSun., Oct. 18MIAFW x Stitch Lab Pop Up - 10:00 AM - 6:00 PM | 350 Miracle Mile, Coral GablesSitka Semsch Fashion Show - 12:00 PM | Miracle MileBeyond the Runway: MIAFW x Stitch Lab, Presented and Hosted by TerranovaFor the first time, Miami Fashion Week and Stitch Lab will join forces for a curated retail pop-up at 350 Miracle Mile in Coral Gables, October 16-18, extending the MIAFW experience beyond the runway. The experience gives designers the opportunity to show, sell and connect directly with consumers, buyers, stylists, content creators, Miami tastemakers and media. Featuring 20+ international designers, shoppers can meet designers, discover new collections and shop ready-to-wear, eveningwear, handbags, shoes and jewelry ahead of the holiday season. Participating designers and brands include NNT, Amarante, IT Shoes, Entos, Ana + Maria, Marea Alta, Paola Pacheco, Francesca Miranda, Maria Angelica Guerra, Muzaluci, Pampa, Adriana Fernandez, Nerea, Ojo de Leon, Beatriz de la Camara, Jhoan Sebastian Grey, Renata Lozano, Vero Diaz, Andres Otalora, Yenny Bastida, Alta Shoes, Jenny Polanco, Adriana Cobo and Hara. Beyond the runway, MIAFW 2026 brings fashion directly to the consumer.Supported by Miami-Dade County, Miami Dade College & Rooted in InclusivityWith the continued support of Miami-Dade County, MIAFW is positioning Miami as a world-class hub for the fashion industry. The event not only attracts global attention but also provides a powerful platform for Latin American talent, inclusivity and cultural diversity, strengthening Miami's role as a vital meeting point between North and South America.From runway shows and a celebratory gala to conversations on fashion, sustainability and technology, plus a new shopping experience on Miracle Mile in partnership with Stitch Lab, Miami Fashion Week's 10th-anniversary program brings fashion into the city in exciting new ways. This milestone also offers an opportunity to thank the sponsors and partners who have helped shape its journey over the years, including Miami-Dade County, Miami Dade College, City of Miami Beach, Mr. C Coconut Grove, and Miami International Airport, whose support has contributed to building a platform that connects Miami with the global fashion community.About Miami Fashion Week®Miami Fashion Week® (MIAFW) is officially recognized by the CFDA's Fashion Calendar Important Dates alongside New York, London, Paris and Milan. Rooted in fashion, art, sustainability and innovation, MIAFW bridges continents by spotlighting Latin American designers, international talent and Miami's own creative community. In 2026, MIAFW celebrates its 10th anniversary, marking a decade of connecting designers, industry leaders and audiences through fashion in Miami. For more information, please visit www.miamifashionweek.com and follow @miamifashionweek.LORA PRLaura Nerouliaslaura@lorapr.comSOURCE: THE FASHION SHOWS LLC Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Hong Kong, Oct 9, 2026 - (ACN Newswire via SeaPRwire.com) - Cheche Group Inc. (NASDAQ: CCG) is pursuing an expansion into residential battery storage and home energy management under its “Green Mobility + Green Energy” two-pillar strategy. The planned expansion would complement its established NEV insurance technology business and support its broader “Car + Home” vision.Cheche’s existing platform connects automakers and insurance carriers to support digital insurance transactions and services. In the first half of 2026, its NEV partnerships generated approximately 1.0 million insurance policies, up 29.5% from a year earlier. Corresponding written premiums rose 23.7% to RMB3.2 billion. The company had partnerships with 18 NEV manufacturers as of June 30, 2026.This business has given Cheche experience in integrating insurance services into automakers’ customer channels. Its technology supports insurance transactions, pricing and claims processes through data integration and risk modeling.For the proposed home energy expansion, Cheche is targeting Long Way Fortune, a residential energy technology provider operating under its brand EnergyLIB. Long Way Fortune brings hardware engineering, modular battery products, and local service capabilities. Its portfolio includes modular batteries and hybrid inverters designed for both retrofit solar-plus-storage and new installations. The business operates in Australia and Singapore, with a model that includes local distribution, installation support and after-sales service.EnergyLIB is also developing home energy management functions that use electricity consumption, solar generation, weather, tariffs and battery operating data. These functions are intended to help households manage electricity costs while accounting for backup power needs and battery usage.Cheche sees a potential role for its insurance technology and business relationships in services around these energy assets, and will explore potential insurance and financing solutions that could help spread customers' upfront payments over time. These offerings remain in the planning stage and would require product development and partner arrangements.The strategic roadmap prioritizes Australia as the initial market, emphasizing local delivery and after-sales support while building towards broader synergies across the EV and green energy value chains, where solar generates power, storage optimizes it, software manages it, and NEVs consume it.Cheche is pursuing the expansion through a proposed strategic investment in Long Way Fortune, bringing together its insurance technology expertise with EnergyLIB’s residential storage solutions to advance the broader "Car + Home" green ecosystem. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SINGAPORE, Oct 9, 2026 - (ACN Newswire via SeaPRwire.com) - Fullerton Fund Management (“Fullerton”) and SGX Group, in partnership with Moomoo Singapore as Supporting Partner, launched the second edition of the Fullerton / SGX Value-Up Singapore Equities Challenge(1) (“The Challenge”) to the public for the first time, inviting Singaporeans and Permanent Residents aged 18 and above to test their investing skills on Singapore-listed small and mid-cap companies over eight weeks, with cash prizes for the top performers.The inaugural Challenge in 2025 was open to students only. This year’s edition adds an Open Category for the public while retaining the Student Category. Participants in both categories will research and manage virtual portfolios of eligible Singapore-listed securities, with a focus on Singapore’s small- and mid-cap (“SMID”) segment. The trading simulation does not involve real capital.The Challenge comes as interest in Singapore’s SMID segment grows. As of 30 June 2026, institutional net buying in SMID stocks had tripled year on year to S$606 million, while daily trading value rose 155% to S$310 million, its highest level since FY2014(2). The Challenge gives participants a structured and practical way to learn more about companies beyond the Straits Times Index.Open CategoryOpen to Singapore Citizens and Permanent Residents aged 18 and above, the Open Category will run from 7 December 2026 to 29 January 2027 over an eight-week online trading period. Participants compete individually, constructing and managing portfolios from an eligible list of Singapore-listed securities. They will be ranked in real time on a leaderboard based on total portfolio return, with cash prizes of S$3,000, S$2,000 and S$1,000 for the top three participants.Student CategoryThe Student Category returns for its second year and is open to Singapore Citizens and Permanent Residents aged 18 and above who are enrolled full-time in polytechnics or universities. Participants compete in teams of four in the same eight-week simulation, using eligible Singapore-listed securities focused primarily on the SMID segment.The top six teams from the qualifying round will advance to an in-person stock-pitch final, where they will present their research and investment thesis to a judging panel. The top three teams will receive cash prizes of S$10,000, S$5,000 and S$3,000. The category is designed to connect classroom learning with practical exposure to investing, industry practitioners and potential 8-month internship opportunities, through the Fullerton Singapore Value-Up Internship Programme.Building disciplined investment habitsThe Challenge is designed to encourage disciplined portfolio construction rather than concentrated bets. Participants must establish positions within the first five trading days. From 14 December 2026, portfolios must maintain at least 80% exposure to eligible securities at the end of each trading day, with cash holdings capped at 20%. When initiating or adding to a position, exposure to any individual eligible security must not exceed 10% of the portfolio’s total value. Each portfolio may hold no more than 30 eligible securities; leverage, margin and derivatives are not permitted.Through the Challenge, participants will be able to:Gain first-hand experience in researching and evaluating Singapore-listed companies.Develop practical habits around portfolio construction, risk management and investment decision-making.Build a stronger understanding of opportunities available within Singapore’s equities market beyond the benchmark index.Ken Goh, Chief Investment Officer, Fullerton Fund Management, said: “Over the past year, we have seen growing interest in Singapore equities, reflecting broader recognition of the depth and diversity of our domestic market. The objective of the Fullerton/SGX Value-Up Singapore Equities Challenge is to motivate participants to identify and capture rising shareholder value, by encouraging young investors and members of the public to research companies, assess their potential and construct portfolios with greater discipline. The Challenge also supports our broader commitment to talent development. Participants from the inaugural Challenge have since joined Fullerton as interns, demonstrating how practical exposure can help inspire and nurture the next generation of investment professionals. Through this Challenge, we hope to contribute to a more informed and engaged Singapore equities market, with a broader base of investors participating in its long-term development.”Ng Yao Loong, Head of Global Financial Markets, SGX Group, said: “In every market, there is a difference between what is well known and what is well understood. The Fullerton/SGX Value-Up Singapore Equities Challenge encourages participants to close that gap by researching the SMID segment, testing their assumptions and forming their own investment perspectives. By opening the Challenge to the public, we hope more people will discover the breadth of the Singapore stock market and deepen their understanding of the businesses behind it.”Jeyson Ng, CEO, Moomoo Singapore said: “We are pleased to support Fullerton and SGX, both of whom are Moomoo’s long-term strategic partners in the Singapore ecosystem, in making investing education more accessible to students and the wider public. Through practical learning resources on Singapore equities, company research and portfolio construction within the Moomoo app, we hope to help participants build the confidence and foundational skills to better understand the market. The Challenge also provides a meaningful platform for us to engage aspiring talent and nurture the next generation of finance and technology professionals.”Registration for both categories is open until 30 November 2026. A participant may register for either the Student Category or the Open Category (provided that it meets the relevant eligibility requirements), but not both. Interested parties may sign up at https://value-up.investsg.asia/(1) Jointly developed by SGX Group and AlphaInvest(2) SGX Group ResearchAbout Fullerton Fund ManagementFullerton Fund Management Company Ltd (“Fullerton”) is an active investment specialist, focused on optimising investment outcomes and enhancing investor experience.We help clients, including government entities, sovereign wealth funds, pension plans, insurance companies, private wealth and retail, from the region and beyond, to achieve their investment objectives through our suite of solutions. Our expertise encompasses equities, fixed income, multi-asset, alternatives and treasury management, across public and private markets.As an active manager, we place strong emphasis on performance, risk management and investment insights. Incorporated in 2003, Fullerton is headquartered in Singapore, and has associated offices in Shanghai, Brunei and Jakarta. Fullerton is part of a multi-asset management group, Seviora, a holding company established by Temasek. Income Insurance, one of Singapore’s leading insurers, is a minority shareholder of Fullerton.For more information, please visit www.fullertonfund.comAbout SGX Group (Singapore Exchange)SGX Group is one of the world’s most trusted international marketplaces, known for its stability and openness. Anchored in Singapore, we enable price discovery, capital formation and risk management across asset classes, supported by resilient infrastructure and robust clearing. We convene issuers, investors and intermediaries to create and grow markets that stand the test of time. Find out more at www.sgxgroup.com.About Moomoo SingaporeMoomoo Singapore is a holistic wealth-tech platform building an intelligent investing ecosystem across its digital platform, physical experience stores and investor education community. Through the moomoo app, it provides everyday investors and professional clients with access to global markets, diverse investment products, advanced trading tools and AI-powered insights.Since launching in March 2021, Moomoo Singapore has evolved beyond an investing platform into a popular financial literacy resource and full-spectrum wealth platform, supporting investors from their first trade to managing sophisticated portfolios. It surpassed two million users in Singapore in June 2026, spanning retail investors to private wealth and institutional clients.Moomoo Financial Singapore Pte. Ltd. is a subsidiary of Nasdaq-listed Futu Holdings Limited (Nasdaq: FUTU). The firm is regulated by the Monetary Authority of Singapore and holds a Capital Markets Services Licence (CMS101000) and Major Payment Institution Licence (PS20200617). It also has exempt financial adviser status and is authorised to provide Digital Payment Token services. Moomoo Trustee (Singapore) Pte. Ltd. is a licensed trust company, while Moomoo Singapore is a DP Clearing Member, SGX-ST Trading Member, and SGX-DT Trading and Clearing Member of Singapore Exchange.Find out more at https://www.moomoo.com/sgFor media queries, please contact:Rishika Tiwariemail: rishika@financialpr.com.sg Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Hong Kong, Oct 9, 2026 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (1952.HK) announced the appointments of Lakshmi Srinivasan, PhD, as Senior Vice President, Head of Translational Medicine, and Brandon Coder, PhD, as Vice President, Translational Sciences & Discovery. Both executives are seasoned scientists in mRNA cancer vaccines, with deep experience spanning early discovery through clinical development and leadership roles in oncology vaccine research at Moderna and other leading biopharmaceutical companies.The appointments further strengthen the Company’s global R&D capabilities in mRNA therapeutics, and support the continued advancement of its proprietary mRNA platform and pipeline. At Everest, they will drive clinical development of the Company’s mRNA programs and expand Everest’s presence in the United States, in line with the Company’s global mRNA R&D strategy, while working closely with the China R&D team.The two scientists previously held leadership roles at Moderna, where they contributed to its mRNA cancer vaccine programs, including mRNA-4157/V940. Their experience spanning early-stage research through clinical development will support the advancement of Everest's proprietary mRNA platform and global clinical development programs. In August 2026, Moderna and Merck announced that mRNA-4157/V940 in combination with Keytruda met the primary endpoint of recurrence-free survival (RFS) and the key secondary endpoint of distant metastasis-free survival (DMFS) in the Phase 3 INTerpath-001 study. The results represent the first positive Phase 3 readout for an individualized neoantigen therapy (INT) and for an mRNA-based cancer therapy.“We are very pleased to welcome Dr. Srinivasan and Dr. Coder to Everest Medicines as we continue to strengthen our global mRNA R&D capabilities,” said Mr. Yifang Wu, Chairman of the Board of Everest Medicines. “Their deep experience in cancer vaccine research, translational medicine, and clinical development will be highly valuable as we advance our proprietary mRNA platform and broader pipeline. Their appointments reflect our continued commitment to investing in world-class talent and advancing our global mRNA strategy.”Dr. Srinivasan is a seasoned immunologist with 20 years of experience advancing innovative immuno-oncology therapeutics from discovery through clinical development. Her expertise spans cancer vaccines, mRNA-LNP technologies, T-cell therapies, and translational development from preclinical research through clinical proof of concept. Prior to joining Everest Medicines, Dr. Srinivasan served as Executive Director and Head of Oncology Translational Medicine at Moderna Therapeutics from 2023 to 2025. She previously held leadership roles at Repertoire Immune Medicines, Neon Therapeutics, which was later acquired by BioNTech, and Sanofi Oncology. Dr. Srinivasan has played a key role in the clinical translation of personalized neoantigen vaccines and has authored multiple high-profile publications in the field. She served as corresponding author on Phase 1b studies of NEO-PV-01 published in Cell (2020) and Cancer Cell (2022), and co-authored publications on Moderna’s intismeran autogene (mRNA-4157/V940), including the Phase 1 KEYNOTE-603 study published in Cancer Discovery (2024) and the three-year follow-up of the randomized Phase 2b KEYNOTE-942 study published in JCO Oncology Advances (2026).Dr. Coder brings more than 11 years of industry experience advancing T cell immunotherapies from discovery through investigational new drug (IND) submissions and early clinical proof of concept, with expertise in cancer vaccines, mRNA/LNP platform technology, and in vivo CAR therapies. Prior to joining Everest Medicines, Dr. Coder held scientific roles at Moderna from 2019 to 2025, most recently as Associate Scientific Director of Cancer Vaccine Research. He served as research and global pharmacology lead for intismeran autogene (mRNA-4157/V940), which reported positive results from the Phase 3 INTerpath-001 study in August 2026, becoming the first personalized neoantigen therapy and mRNA cancer therapy to achieve success in a Phase 3 clinical study. Dr. Coder also co-invented and led development of the shared-antigen discovery and vaccine design framework for mRNA-4359 and mRNA-4106. He contributed to nine IND submissions as a co-inventor, research lead, or core contributor, and co-authored the Phase 1 KEYNOTE-603 study of mRNA-4157/V940 published in Cancer Discovery (2024). Prior to joining Moderna, Dr. Coder served as Associate Director of Immuno-Oncology Research at Advaxis Immunotherapies, where he developed personalized and off-the-shelf cancer vaccines.Leveraging its proprietary AI+mRNA platform, Everest Medicines is advancing multiple mRNA oncology therapeutic vaccine and in vivo CAR-T programs for oncology and autoimmune diseases. EVM16, a personalized mRNA therapeutic cancer vaccine, has completed its first-in-human clinical data readout, demonstrating a favorable safety and tolerability profile, robust immunogenicity and promising preliminary efficacy. Selected data were presented at the 2026 American Association for Cancer Research (AACR) Annual Meeting. Following the Phase 1a study, EVM16 plans to initiate an investigator-initiated trial (IIT) Phase 1b study in Q4 2026 and launch new indication expansion cohorts for efficacy exploration. The company plans to submit an IND application to the U.S. Food and Drug Administration (FDA) in the first half of 2027. EVM14, an off-the-shelf tumor-associated antigen (TAA) mRNA cancer vaccine, received IND clearance from the U.S. FDA and IND approval from China’s National Medical Products Administration (NMPA) in 2025. The Phase 1 monotherapy dose-escalation study is expected to be completed in Q1 2027.EVM18, an in vivo CAR-T therapy, has initiated an IIT study in autoimmune diseases, with global IND filing underway. EVM15, an off-the-shelf immunomodulatory (IM) cancer vaccine, achieved clinical proof of concept in preclinical studies in 2025, with a clinical candidate subsequently selected. The Company plans to advance preparations for the Investigational New Drug (IND) application for EVM15 in 2026. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

BRUSSELS, BELGIUM, Oct 9, 2026 - (ACN Newswire via SeaPRwire.com) - Most recently, the Airwheel SE3SX Smart Rideable Cabin Suitcase was honored with a 2026 European Product Design Award (EPDA) Winner title, marking yet another milestone in the brand's relentless pursuit of innovation. Airwheel, a pioneering smart mobility brand, has cemented its position as a global design leader with its intelligent rideable luggage series accumulating over 100 prestigious international awards across the United States, Europe, Japan, Italy, Germany, France, and London.The EPDA, alongside the MUSE Design Awards and IDEA Awards—all established by the International Awards Associate (IAA)—represent the pinnacle of global industrial design recognition. An international jury evaluates entries across innovation, aesthetic expression, practical implementation, human-machine interaction, and user experience. Airwheel's repeated success across these platforms underscores its design philosophy: "Let design return to real travel."Award-Winning Products Under the SpotlightAirwheel SE3S Smart Electric SuitcaseAward Portfolio: 2023 MUSE Design Award, IDA Award, Italy IIDA Award; 2024 French Design Award, London Design Award (Best of Year), American Good Design Award (Silver), Paris DNA Design Award, NY Product Design Award (Silver); 2025 German National Design Award (Winner), Italy A' Design Award (Silver)MUSE Jury Commentary: "The Airwheel SE3S revolutionizes the traditional suitcase by integrating electric rideability with smart storage. Its patented high-strength frame and modular detachable lithium battery enable seated mobility while meeting stringent aviation regulations—delivering an effortless, elegant travel experience for frequent flyers."As the flagship pioneer of Airwheel's rideable luggage line, the SE3S features a 20-inch carry-on form factor combining rideable transportation, smart storage, and on-the-go charging. Its high-strength hard shell and patented reinforced frame support rider weight, while dual-handlebar controls ensure intuitive operation. The modular plug-and-play lithium battery requires no tools for removal and complies with civil aviation standards.Airwheel SE3SX Smart Rideable Cabin SuitcaseAward Portfolio: 2026 European Product Design Award (Winner), WGA Creative Global Design Award (Silver), iLuxury International Luxury Award, Titan Innovation Award (Platinum)EPDA Jury Commentary: "The Airwheel SE3SX redefines the value boundary of carry-on luggage as a 'smart travel terminal,' seamlessly integrating high-performance electric drive, intelligent interaction, and aviation-grade lightweight design. Its innovative electric telescopic front-wheel structure enhances riding stability, while Apple Find My and a dedicated smart app deliver natural human-machine interaction. The 73.26Wh detachable battery and TSA lock ensure global compliance—a design benchmark for premium international business travel."The SE3SX packs a 230W high-performance brushless motor delivering speeds up to 9.9km/h, a 95kg load capacity, and 6° hill-climbing capability. Its innovative electric telescopic front-wheel structure extends the wheelbase by 180mm at the touch of a button. The body combines lightweight ABS+PC materials with an aviation-grade aluminum alloy frame, weighing approximately 6.6kg (excluding power bank), with dimensions of 530×360×236mm and a 20L capacity. Features include Apple Find My global tracking, a dedicated smart app, 5V USB charging, a detachable 73.26Wh lithium battery, and a TSA customs lock—approved for both air and high-speed rail travel.Airwheel SE3SXD Ai Luxury SuitcaseThe SE3SXD elevates the travel experience with an integrated smart interaction system and linked smart handle, enabling one-touch switching between suitcase form and riding mode. Its dual-drive automatic telescopic mechanism extends and retracts the structure with a single touch—transforming luggage into an intelligent travel companion.Airwheel SE3MiniT Electric Hand SuitcaseAward Portfolio: 2024 European Design Award, London Design Award (Platinum), NY Product Design Award (Gold), American Good Design Award (Bronze), Paris DNA Award (Honorable Mention), French Design Award (Honorable Mention); 2025 Italy A' Design Award (Silver), World Design AwardEuropean Design Award Jury Commentary: "The Airwheel SE3MiniT addresses urban short-distance travel with ultimate lightweight design, distilling complex rideable luggage functions into a pure 'travel light' experience. Its compact form and convenient rideability make city commutes and weekend getaways effortless—showcasing nuanced thinking for segmented smart mobility scenarios."Designed for urban commuting and weekend excursions, the SE3MiniT retains Airwheel's signature rideable functionality in a compact, lightweight body—ideal for high-frequency, short-distance metropolitan travelers.Airwheel SE3SL / SE3SL+ Ai Wheel Airport Boarding SuitcaseAward Portfolio: SE3SL—2025 Berlin Design Award (Gold), Shanghai Design Award, US IDEA Award, IAI Design Award, New Quality Award, Japan IDPA Design Award (Silver), 2026 Asian Design Award; SE3SL+—2025 US AIIDA Design Award, Boiling Quality Award (Gold)IDEA Jury Commentary: "The Airwheel SE3SL organically combines smart mobility concepts with mainstream business luggage forms. At just 6.6kg, its ultra-lightweight design integrates rideability, app connectivity, USB charging, and location tracking—achieving an outstanding balance between innovation, user experience, and commercial value. A mature offering for high-frequency business travel."Targeting premium business travelers, the SE3SL/SE3SL+ series integrates rideable transportation, smart app connectivity, USB charging, and Apple Find My tracking—blending aesthetics with practicality for both short-haul and international business scenarios.Airwheel SQ3S Smart Kids SuitcaseAward Portfolio: 2025 French Design Award (Gold), MUSE Design Award (Silver), American Good Design Award (Bronze), NY Product Design Award (Gold)French Design Award Jury Commentary: "The Airwheel SQ3S enters the family travel scene with a safety-first design language, achieving a balance of 'storable, rideable, and reassuring' in a children's smart suitcase. Its safety speed-limit design fully considers children's riding safety, making family travel both fun and secure—embodying design's gentle care for real family needs."The SQ3S is Airwheel's dedicated smart suitcase for family travel, combining ample storage with child-friendly rideable fun, featuring a safety speed-limit design for secure, enjoyable family experiences.Meet Airwheel at the 140th Canton FairFollowing its continued recognition in international design competitions, Airwheel invites distributors, importers, retailers, business partners, and visitors from around the world to meet its team at the 140th China Import and Export Fair (Canton Fair) in Guangzhou, China.Airwheel will participate across all three phases of the exhibition, presenting its intelligent rideable luggage and smart mobility solutions to international buyers and industry professionals. Visitors will have the opportunity to explore Airwheel’s product portfolio, experience selected products firsthand, learn more about its latest developments in smart travel technology, and discuss potential distribution partnerships and business opportunities.From smart rideable cabin suitcases to its latest intelligent luggage concepts, Airwheel looks forward to connecting with global partners and exploring opportunities to bring innovative mobility solutions to more markets.Global buyers and potential distribution partners are warmly invited to visit Airwheel’s booths and meet the team in person.Exhibition: 140th China Import and Export Fair (Canton Fair)Venue: China Import and Export Fair Complex, Guangzhou, ChinaPhase 2: October 23–27, 2026 | Booth 20.2F19–20Phase 3: October 31–November 4, 2026 | Booth 20.2J37–38,20.2K11-12, 18.1K04For international buyers seeking to expand their smart luggage portfolio, explore retail opportunities, or discuss regional distribution, the Canton Fair provides an opportunity to connect directly with Airwheel and learn more about its products and international partnership opportunities.Brand-Level Honors and Future OutlookAs a pioneer of the smart rideable luggage category, Airwheel has built a clear and robust competitive moat through core technologies. To date, the company has secured over 600 patents globally, covering motion control algorithms, electric drive systems, intelligent perception, and structural design—including multiple international invention patents. Airwheel's trademarks are registered in over 168 countries and regions, providing a solid foundation for compliant operations, scalable promotion, and long-term brand building across diverse markets.Behind these honors lies over a decade of deep cultivation in the smart mobility sector. From its first German iF Design Award to now holding over 100 international certifications across the US, Europe, Japan, Italy, France, and the UK, Airwheel continues to showcase the power of persistent innovation. Looking ahead, the brand will continue integrating cutting-edge intelligent perception and human-machine interaction technologies—embedding technology into every journey and delivering smart mobility innovations to global markets.About AirwheelAirwheel is a leading smart mobility brand specializing in intelligent rideable luggage and personal mobility solutions. Guided by its design philosophy “Let design return to real travel”, Airwheel combines electric drive, smart interaction and aviation-grade materials to redefine travel experiences. Boasting over 600 global patents and more than 100 international awards, Airwheel, as one of the world’s leading smart mobility device manufacturers, strives to unleash the joy of technology and uphold its corporate culture: “Free Intelligent Life”.Media ContactCompany: AirwheelContact: Media TeamWebsite: https://www.airwheel.net Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Hong Kong, Oct 9, 2026 - (ACN Newswire via SeaPRwire.com) - As AI Drug Development Approaches Commercialization, MindRank Marks a Key Business MilestoneHow much value can AI create in the discovery and development of new medicines' For investors following the sector, the answer lies in tangible progress in drug development and business execution. A platform’s ability to consistently generate drug candidates, advance lead assets through clinical development and secure recognition from industry partners provides an important basis for assessing an AI drug developer’s growth potential.The recently announced commercialization partnership by MindRank AI Ltd. (MindRank, hereinafter “MindRank”) offers a new window into this question.On September 28, 2026, MindRank announced an exclusive commercialization partnership with 3SBio (01530.HK) subsidiaries Sunshine Mandi and Wansheng Pharmaceutical for MDR-001, its internally developed, AI-designed oral small-molecule GLP-1 receptor agonist. Covering mainland China, Hong Kong and Macau, the agreement carries a potential total transaction value of up to RMB1.75 billion, alongside a substantial share of sales revenue. MDR-001 is currently undergoing a pivotal Phase III clinical trial in China in adults with obesity or overweight.For MindRank, a clinical-stage AI-native drug discovery and development technology company, the partnership further connects drug development with commercialization planning. It lays the groundwork for marketing its lead asset following potential approval and establishes a clearer pathway for translating AI-driven research into commercial value. As its lead asset advances through pivotal clinical development, MindRank has begun preparing for post-approval marketing and channel coverage, extending the product’s development pathway into commercialization.Under the agreement, Sunshine Mandi and Wansheng Pharmaceutical will provide exclusive, comprehensive services and distribution across all channels following MDR-001’s launch. MindRank will retain all rights, title and interests in the product’s intellectual property and remain responsible for clinical development, regulatory submissions, manufacturing and supply. The transaction includes up to RMB150 million in payments for collaboration rights, up to RMB1.6 billion in royalty payments upon the fulfillment of agreed conditions, and a substantial share of sales revenue.From a business-model perspective, the agreement establishes a clear division of responsibilities. MindRank will continue investing in research and product development, while its partners will provide exclusive, comprehensive services and distribution across all channels within the agreed territories following regulatory approval and launch. In an industry that requires sustained investment, this collaboration could help MindRank retain its core asset rights while drawing on its partners’ commercial capabilities to support launch preparations and focus its own resources on strengthening its core capabilities.The partners’ willingness to make commercialization arrangements for an investigational drug also provides a new reference point for assessing its potential industry value. Clinical data address whether a product merits further development, while commercial partnerships indicate whether industry participants are willing to take part in its subsequent development. Together, these elements make MindRank’s growth story more tangible.A Lead Asset in Phase III Provides a Clearer Basis for Assessing AI-Driven R&D CapabilitiesThe core asset underpinning the partnership is MDR-001, which continues to advance through development.In February 2026, MindRank announced that the first participant had been dosed in MOBILE, its Phase III clinical trial of MDR-001. According to the company, the multicenter, randomized, double-blind, placebo-controlled study plans to enroll approximately 750 participants across around 50 clinical centers in China to further evaluate the product’s long-term efficacy and safety.This means the evidence available to assess MindRank’s AI-driven R&D capabilities now extends to larger-scale, late-stage clinical research. For investors, the lead asset’s entry into Phase III sharpens the focus on several key questions: whether long-term efficacy can be further validated, whether safety and tolerability findings can be sustained, and whether the product can establish clinically meaningful competitive advantages.Previously disclosed Phase IIb findings supported further development. In the study, which enrolled 317 adults with obesity or overweight, participants in the MDR-001 dose groups achieved mean reductions in body weight from baseline of 8.2% to 10.3% after 24 weeks, compared with 2.5% in the placebo group. The rate of treatment discontinuation due to treatment-emergent adverse events was 0.8%. Common adverse events were primarily gastrointestinal and mostly mild to moderate. These findings remain subject to further validation in subsequent studies.For weight-management medicines, product value depends on a combination of weight-loss efficacy, long-term safety, tolerability and ease of use. Compared with the injectable peptide-based GLP-1 medicines that currently dominate the market, MDR-001’s oral small-molecule formulation can significantly improve medication adherence, while its large-scale manufacturing costs are substantially lower than those of peptide-based medicines, offering considerable market potential and commercial value. These attributes provide a promising direction for its future product positioning, although translating them into a competitive advantage will require continued accumulation of clinical evidence.Beyond progress in product development, R&D efficiency is another important lens through which to assess MindRank.According to the company, MDR-001 progressed from project initiation to preclinical candidate (PCC) nomination in just eight months, during which approximately 80 small molecules were synthesized. Its investigational new drug (IND) application was cleared in the United States within 19 months of project initiation and MDR-001 advanced to Phase III in China in approximately 4.5 years. In its July 2026 financing announcement, the company further disclosed that cumulative direct R&D investment in the program, from initiation through the start of Phase III in China, totaled approximately US$23 million.These timelines and investment figures provide a more concrete basis for understanding how MindRank organizes drug discovery and development. For drug developers, development timelines and funding requirements directly affect how many programs they can advance, how long they can sustain development and how they allocate resources to subsequent work. AI’s commercial significance must also be assessed within these real-world R&D constraints.As a flagship application of MindRank’s AI-driven drug discovery and development system, MDR-001 offers a traceable development pathway: from molecular design to clinical research and, subsequently, commercialization partnerships. The platform’s capabilities are beginning to be tested through tangible business outcomes. This provides capital markets with a more useful basis for understanding the company’s technology value than descriptions of algorithms or model parameters alone.Beyond the Lead Asset, Long-Term Growth Depends on Sustained Platform OutputMDR-001 is the central focus of MindRank’s business progress at this stage, while the company’s long-term growth potential also depends on its ability to continue developing new drug assets.According to the MindRank, its end-to-end AI drug development engine, MAP (Molecule Arts Platform), integrates biology, chemistry, computation, experimental validation and clinical learning into a unified drug discovery and development system. In July 2026, the company announced that it had completed a cumulative US$52 million Series B financing in stages, with proceeds earmarked for further platform development and the advancement of its clinical and preclinical pipeline. In September 2026, the company formally launched Intera (Intelligence Era), its life-sciences foundation model system, and released a technical report on InteraFold-Chem, the first model in the InteraFold series.From an operating perspective, platform development and pipeline advancement have the potential to reinforce each other. R&D programs bring real-world problems and experimental feedback to the platform, while platform iterations support the discovery and optimization of subsequent programs. Ultimately, the platform’s value must be reflected in sustained output: its ability to advance more molecules with development potential across different targets and disease areas, gradually building a business supported by multiple assets.MindRank has already expanded beyond metabolic diseases. In March 2025, the company disclosed that MRANK-106, an oral dual inhibitor of WEE1 and YES1, had received IND approval in the U.S. in oncology. This development provides another case through which to assess the applicability of its AI platform across different R&D areas, although the product’s potential remains subject to subsequent clinical validation.In earlier-stage research, the company disclosed in April 2026 that a collaborative study on drug discovery for Alzheimer’s disease, conducted by MindRank, the University of Macau and Imperial College London, had been published in Nature Biomedical Engineering. The work combined AI screening with experimental validation to identify small molecules meriting further investigation, demonstrating the company’s research capabilities and exploration at the forefront of drug discovery for complex diseases.These programs are at different stages, and their contributions to the company’s value need to be assessed separately. MDR-001 remains the main focus of current clinical development and commercialization preparations, while other pipeline programs and research support the platform’s broader applicability and long-term project portfolio. As more programs deliver verifiable progress, outside observers will be better positioned to assess whether the company can consistently replicate its R&D capabilities.Viewed through this lens, the recent commercialization partnership offers an opportunity to reassess MindRank. Its lead asset has entered pivotal clinical development, partners are participating in commercialization preparations at an early stage, financing supports continued R&D, and its presence across multiple areas preserves opportunities for future growth. These interconnected developments make the company’s development trajectory easier for capital markets to understand.MDR-001 remains in clinical development and has not yet received marketing approval. Its future value realization depends on clinical results, regulatory approval and commercial execution. Nevertheless, the business progress achieved to date provides a more concrete basis for assessing MindRank. For investors following opportunities at the intersection of AI and innovative medicines, the central question worth tracking is whether the company can progressively translate its established R&D capabilities into more verifiable drug assets and commercial outcomes. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

TORONTO, ON, Oct 9, 2026 - (ACN Newswire via SeaPRwire.com) - TMX Group today announced its financing activity on Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) for September 2026.TSX welcomed 28 new issuers in September 2026, compared with 14 in the previous month and 29 in September 2025. The new listings were 27 exchange traded funds and one mining company. Total financings raised in September 2026 decreased 36% compared to the previous month, but were up 263% compared to September 2025. The total number of financings in September 2026 was 53, compared with 29 the previous month and 55 in September 2025.For additional data relating to the number of transactions billed for TSX, please click on the following link: https://www.tmx.com/resource/en/440.There were five new issuers on TSXV in September 2026, compared with three in the previous month and three in September 2025. The new listings were three mining companies, one financial services company and one life sciences company. Total financings raised in September 2026 increased 69% compared to the previous month, and were up 60% compared to September 2026. There were 88 financings in September 2026, compared with 77 in the previous month and 119 in September 2025.TMX Group consolidated trading statistics for September 2026 can be viewed at www.tmx.com.Toronto Stock Exchange September 2026August 2026September 2025Issuers Listed229622751,976New Issuers Listed281429IPOs271227Graduates from TSXV131Issues Listed2,9532,9302,630IPO Financings Raised$139,734,076$356,716,460$59,050,000Secondary Financings Raised$3,942,203,252$5,571,740,370$735,357,479Supplemental Financings Raised$776,006,697$3,468,750$543,680,650Total Financings Raised$4,857,944,025$5,931,925,580$1,338,088,129Total Number of Financings532955Market Cap Listed Issues$7,046,648,640,029$7,253,321,243,857$5,962,344,835,101 Year-to-date Statistics 20262025% change New Issuers Listed270225+20.0IPOs230203+13.3Graduates from TSXV197+171.4IPO Financings Raised$2,793,238,974$1,532,755,260+82.2Secondary Financings Raised$19,499,634,913$5,828,747,507+234.5Supplemental Financings Raised$1,463,146,557$3,979,404,333-63.2Total Financings Raised$23,756,020,444$11,340,907,100+109.5Total Number of Financings442423+4.5Market Cap Listed Issues$7,046,648,640,029$5,962,344,835,101+18.2 TSX Venture Exchange** September 2026August 2026September 2025Issuers Listed1,7041,7061,795New Issuers Listed533IPOs011Graduates to TSX131Issues Listed1,7601,7601,860IPO Financings Raised$0$500,000$500,000Secondary Financings Raised (1)$237,591,376$53,291,379$123,899,190Supplemental Financings Raised$767,167,449$540,904,315$505,554,235Total Financings Raised$1,004,758,825$594,695,694$629,953,425Total Number of Financings8877119Market Cap Listed Issues$132,590,780,228$142,429,746,905$131,725,663,502 Year-to-date Statistics 20262025% ChangeNew Issuers Listed3627+33.3IPOs116+83.3Graduates to TSX197+171.4IPO Financings Raised$24,159,272$13,734,685+75.9Secondary Financings Raised (1)$2,146,093,763$1,080,336,575+98.7Supplemental Financings Raised$7,000,449,034$4,364,785,594+60.4Total Financings Raised$9,170,702,069$5,458,856,854+68.0Total Number of Financings1,032950+8.6Market Cap Listed Issues$132,590,780,228$131,725,663,502+0.7 **Includes NEX (not applicable to New Issuers Listed, IPOs and IPO Financings Raised)(1) Secondary financings include prospectus offerings on both a treasury and secondary basisThe information contained in this media release is provided for informational purposes only and is not intended to provide investment, trading, financial or other advice. Comparative data has been updated to reflect known corrections.TMX Group welcomes the following companies that listed during September 2026:Toronto Stock ExchangeIssuer NameCompany SymbolBMO Strategic Autocallable Income US Large Cap ETFZACUCI Munro International Growth Equity FundCMIGCorton Rosenberg Global Macro FundROSYCorton Theta Alpha FundTPUTGlobal X 1-10 Year Canadian Corporate Bond Index ETFGCIGGlobal X 3-10 Year U.S. Treasury Bond Index ETFTMTXGlobal X Artificial Intelligence Memory Index ETFDRAMGlobal X Asia Semiconductor Index ETFACHPGlobal X Canadian Universe Bond Index ETFAGGXGlobal X Korea KOSPI 200 Index ETFKORXGlobal X S&P/TSX Capped Composite Index ETFCNDCManulife All-Equity ETF PortfolioMEQPManulife All-Fixed Income ETF PortfolioMBNDManulife Corporate Bond FundCORBManulife Smart International Dividend ETF - USDIDUV.UMiddlefield Alternative Global Fixed Income FundMAGFMiddlefield Global Multi-Sector Fixed Income FundMGFINBI SmartData Enhanced Yield U.S. Equity FundNSUYNBI SmartData International Equity Covered Call FundNICCNBI SmartData U.S. Equity Covered Call FundNUCCNBI Target 2032 Investment Grade Bond FundNTGGNBI Ultra Short-Term Fixed Income FundNUSTNinepoint Enhanced Aerospace and Defense HighShares ETFEDHINinepoint Enhanced U.S. Equity HighShares ETFUSHISantacruz Silver Mining Ltd.SCZTD Q International Dividend ETFTQIDVanguard Global Core-Plus Bond ETFVCORWestcourt Hamilton Yield Portfolio ETFWHYP TSX Venture ExchangeIssuer NameCompany SymbolAlex Metals Corp.ALXCrown Capital Partners Inc.CRWNGreen Canada Uranium Corp.GCUCNAIA Relief Inc.NAIAStardust Metal Corp.ZIGY About TMX Group (TSX:X)TMX Group operates global markets, and builds digital communities and analytic solutions that facilitate the funding, growth and success of businesses, traders and investors. TMX Group's key operations include Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange, TMX Australia Exchange, The Canadian Depository for Securities, Montréal Exchange, Canadian Derivatives Clearing Corporation, TSX Trust, TMX Trayport, TMX Datalinx, TMX VettaFi and TMX Newsfile, which provide listing markets, trading markets, clearing facilities, depository services, technology solutions, data products and other services to the global financial community. TMX Group is headquartered in Toronto and operates offices across North America (Montréal, Calgary, Vancouver and New York), as well as in key international markets including London, Singapore, Vienna and Sydney. For more information about TMX Group, visit www.tmx.com. Follow TMX Group on X: @TMXGroup.For more information, please contact:Catherine KeeHead of Media RelationsTMX Group416-671-1704catherine.kee@tmx.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/317996 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

TORONTO, ON, Oct 8, 2026 - (ACN Newswire via SeaPRwire.com) - TMX Group Limited will announce its financial results for the third quarter ended September 30, 2026 in the evening of Thursday, October 29, 2026. An analyst conference call to review the results will be held on Friday, October 30, 2026 at 8:00 a.m. ET.WHAT:TMX Group Limited Q3 2026 financial results analyst conference call WHO: John McKenzie, Chief Executive Officer, TMX GroupDavid Arnold, Chief Financial Officer, TMX GroupAmanda Tang, Director, Investor Relations, TMX Group WHEN: Friday, October 30, 2026, 8:00 a.m. ET HOW: Participants may access the conference call via the webcast link. The audio webcast of the conference call will also be available and archived in TMX's shareholder events section. About TMX Group (TSX: X)TMX Group operates global markets, and builds digital communities and analytic solutions that facilitate the funding, growth and success of businesses, traders and investors. TMX Group's key operations include Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange, TMX Australia Exchange, The Canadian Depository for Securities, Montréal Exchange, Canadian Derivatives Clearing Corporation, TSX Trust, TMX Trayport, TMX Datalinx, TMX VettaFi and TMX Newsfile, which provide listing markets, trading markets, clearing facilities, depository services, technology solutions, data products and other services to the global financial community. TMX Group is headquartered in Toronto and operates offices across North America (Montréal, Calgary, Vancouver and New York), as well as in key international markets including London, Singapore, Vienna and Sydney. For more information about TMX Group, visit www.tmx.com. Follow TMX Group on X: @TMXGroup.For more information, please contact:Catherine KeeHead of Media RelationsTMX Group416-671-1704catherine.kee@tmx.comAmanda TangDirector, Investor RelationsTMX Group416-895-5848amanda.tang@tmx.com To view the source version of this press release, please visit https://www.newsfilecorp.com/release/317948 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

BRISBANE, AUS, Oct 8, 2026 - (ACN Newswire via SeaPRwire.com) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to provide the latest progress update on the next generation graphene battery technology being developed by GMG under a Joint Development Agreement with Rio Tinto, one of the world's largest metals and mining groups, and with the support of the Battery Innovation Center of Indiana ("BIC") in the United States of America.GMG is pleased to share the following cycling data of GMG's fast charging G®CELLS (1.5 Ah cells with 6 minute charging) as seen in Figure 1, with energy density and energy efficiency graphs shown in Figure 2. This data was collected by the BIC on cells that were made by the BIC with materials that were developed, manufactured and supplied by GMG in its Brisbane Battery Development Centre.Figure 1 shows that G®CELLS have cycled with no performance reduction after 1000 cycles, as at October 7th 2026, which is a doubling of cycle life since the previous GMG battery performance announcement1, despite being charged and discharged in 6 minutes (at 7C). Figure 1 also shows the performance of a well-known Lithium Titanate Oxide (LTO) battery which, when charged and discharged at the same time of 6 minutes (at 10C) degraded to 80% of original capacity (which is typically the declared end of life of a cell) within 82 cycles. Another G®CELL was also charged and discharged in 6 minutes (at 10C) and registered only a 10% reduction after 393 cycles. The G®CELLS effectively last 10 times longer whilst being charged and discharged in the same time.Figure 1: GMG G® CELLS and LTO Cycling DataTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/318037_08d51822742ee86a_001full.jpgFigure 2 shows a 48% increase of the energy density of 58 Wh/kg whilst being charged in 6 minutes (at 10C) over previous reported energy density of 39 Wh/kg in GMG's previous battery performance announcement1.The G®CELLS also show a 94% energy efficiency which is high especially at such a high charge and discharge rate - when compared to the 64% energy efficiency of the tested LTO.Figure 2: GMG G® CELLS and LTO Energy Density and Energy Efficiency DataTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/318037_08d51822742ee86a_002full.jpgBob Galyen, GMG Director and former Chief Technology Officer of CATL, commented: "The cycling stability we are seeing from these G®CELLS is genuinely exceptional. Reaching 1,000 cycles with no performance reduction, while every cycle is charged and discharged in six minutes, stands in stark contrast to the LTO benchmark cell. LTO is regarded as one of the most robust fast-charging chemistries on the market today, yet it degraded to 80% of its original capacity within 82 cycles under the same six-minute charge and discharge time. Just as important is the 94% energy efficiency at these high rates, compared with 64% for the LTO cell. Energy that isn't lost as heat is what makes fast charging practical at the system level. Having built and scaled battery manufacturing for the world's largest lithium-ion producer, I know how rare it is to see fast-charge durability, high efficiency and rising energy density together this early in a cell's development. There is further work ahead on extending cycle life at 10C and scaling the cell size, but the fundamentals being demonstrated here are the right ones to be solving first."Craig Nicol, Chief Executive Officer and Managing Director of GMG, commented: "This data set from BIC is an important proof point for our graphene battery program. Since our last update we have doubled cycle life to 1,000 cycles with no performance reduction and lifted energy density by 48% to 58 Wh/kg at a 10C charge rate. We have also achieved 94% energy efficiency, all while charging and discharging in six minutes. Fast charging is one of the biggest barriers to broader electric vehicle and energy storage adoption. These results show G®CELLS lasting around ten times longer than a comparable LTO cell charged and discharged in the same time. Our focus now is on continuing to improve energy density and 10C cycle life, and on scaling to larger cell formats. I want to thank the team at BIC and our partners at Rio Tinto for their continued collaboration as we progress this technology along the roadmap."Jack Perkowski, Chairman of GMG, commented: "Battery development of this kind requires patient capital, disciplined engineering and world-class partners, and this update reflects progress on all three fronts. Since our last update, cycle life has doubled and energy density has risen by 48%. This data was generated by BIC, an organisation with over 10 years of experience and more than 500 battery development projects behind it, on cells built with GMG's graphene materials. That gives the Board real confidence in the direction of this program. Combined with the ongoing support of Rio Tinto, I believe GMG is building the right foundations to advance this technology toward commercial relevance. The Board will continue to support management as they work through the optimisation and scale-up steps ahead."Please see the following webpage for further details about the graphene batteries: https://graphenemg.com/graphene-products/gcells/. The G®CELLS are in pouch format - as seen in Figure 3. The launch video link for G®CELLS is shown in Figure 4.Figure 3: G Cell Pouch Cell BatteryTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/318037_08d51822742ee86a_003full.jpgFigure 4: G®CELLS Launch VideoLaunch video: https://youtu.be/pfHhh5-TLyUTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/318037_08d51822742ee86a_004full.jpgLaunch video: https://youtu.be/pfHhh5-TLyUAbout BIC:BIC is a collaborative initiative designed to incorporate leadership from renowned universities, government agencies, and commercial enterprises. BIC is a public-private partnership and a not-for-profit organization focusing on the rapid development, testing and commercialization of safe, reliable and lightweight energy storage systems for defense and commercial customers. BIC is a unique organization that has been leading battery cell development for world leading battery companies for over 10 years and has carried out over 500 battery development projects.About GMGGMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines. GMG has also developed a graphene water based coolant additive focused on increasing heat transfer and reducing bacterial growth in cooling water circuits.In the energy storage segment, GMG is working collaboratively with financial support from the Australian Government to progress R&D and commercialization of GMG Graphene Batteries. GMG has also developed a graphene additive slurry that is aimed to improve the performance of lithium-ion batteries.GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information, please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com.Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041.www.graphenemg.comNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking StatementsThis news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include, without limitation:statements that GMG Graphene Batteries are safe and fast charging, and that graphene can be used to increase their performance and cycle life;statements regarding the Company's ability to further improve the energy density, cycle life (including at a 10C charge rate) and energy efficiency of G®CELLS, and to scale the cell size;GMG's intentions to develop commercial scale-up capabilities;GMG's focus in the energy savings segment;GMG's intentions for the use of graphene lubricant additive on saving liquid fuels;expectations for R&D and commercialisation of Graphene Batteries;GMG's ability to improve the performance of lithium-ion batteries;statements attributed to Bob Galyen, Craig Nicol and Jack Perkowski regarding the significance of the BIC cycling, energy density and energy efficiency data, the Company's technology, partnerships and commercial prospects; andthe Company's four critical business objectives.Such forward-looking statements are based on a number of assumptions of management, including, without limitation:assumptions that GMG Graphene Batteries can be produced at lower cost;assumptions as to charging time, energy density, energy efficiency, life cycle, safety, thermal runaway risk and the need for a thermal management system for GMG Graphene Batteries, and the speed and stability of charging;that G®CELLS will continue to cycle without material performance reduction beyond the cycles reported in this news release;that GMG Graphene Batteries will progress to BTRL 7 and 8;that a range of global companies in a variety of industries will be interested in working with GMG;that the battery pack design will be plastic and offer weight, cost and complexity advantages to a metal case and increased energy density;that the service agreement with the BIC will enable the Company to optimize its cell design and battery manufacturing equipment;that the Company will be able to further improve energy density and 10C cycle life, and scale the cell size, as anticipated; andthat the Company will be able to meet its overall timeline on the battery cell roadmap.Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation:that GMG Graphene Batteries cannot be produced at lower cost, or that any of the assumptions as to charging time, energy density, energy efficiency, life cycle, scaling of the cell size, safety, thermal runaway risk and the need for a thermal management system for GMG Graphene Batteries cannot be achieved;that GMG Graphene Batteries do not offer expected speed and stability of charging;that cycling testing, which is ongoing as at October 7, 2026, will show performance reduction in later cycles;that GMG Graphene Batteries will not progress to BTRL 7 and 8;that a range of global companies in a variety of industries will not be interested in working with GMG;that the battery pack design will not be plastic and will not offer weight, cost and complexity advantages to a metal case and increased energy density;that the Company will not be able to optimize the electrochemical behaviour of the pouch cell through laboratory experimentation or at all;that the Company will not be able to further improve energy density or 10C cycle life, or scale the cell size, as anticipated or at all;that the Company will not be able to meet its overall timeline on the battery cell roadmap;that the service agreement with the BIC will not enable the Company to optimize its cell design and battery manufacturing equipment;that further testing or larger-format cells will not replicate the cycling, energy density or energy efficiency performance reported in this news release;that the Joint Development Agreement with Rio Tinto will not continue on the terms or timeline currently anticipated;that GMG's operations could be adversely affected by possible future government legislation, policies and controls, by changes in applicable laws and regulations, or by the failure to obtain all necessary regulatory approvals;that public health crises such as pandemics may adversely impact GMG's business and the ability of the Company to develop its products;the volatility of global capital markets;political instability;the failure of GMG to attract and retain skilled personnel;unexpected development and production challenges;that GMG could face technology or software disruptions;unanticipated costs;risks relating to the extent and duration of the conflicts in Eastern Europe and the Middle East and their impact on global markets;that the Company will be unable to develop, market, and sell its products as currently anticipated;that the Company will be unsuccessful in identifying and engaging strategic partners;that the Company will be unable to acquire equipment to streamline its production process, or that the expansion of its production facilities will not result in the benefits currently expected;that companies currently working with GMG, or parties that have entered into NDA arrangements with the Company, will not be interested in purchasing the Company's products;that GMG's products may not perform as anticipated or deliver the expected commercial benefits;that GMG's proprietary production processes may not provide an alternative to traditional graphite supply chains;that the Company will be unable to grow its sales or revenues as anticipated;that third-party market data and industry projections will not be accurate as presented; andthe risk factors set out under the heading "Risk Factors" in the Company's annual information form dated November 04, 2025, available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that is incorporated by reference herein, except in accordance with applicable securities laws.1 https://graphenemg.com/gmg-announces-long-life-battery-cycling-data/To view the source version of this press release, please visit https://www.newsfilecorp.com/release/318037 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com